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 Preface 
The main task of the Nordic Expert Group for Criteria Documentation of Health 
Risks from Chemicals (NEG) is to produce criteria documents to be used by the 
regulatory authorities as the scientific basis for setting occupational exposure 
limits for chemical substances. For each document, NEG appoints one or several 
authors. An evaluation is made of all relevant published, peer-reviewed original 
literature found. The document aims at establishing dose-response/dose-effect 
relationships and defining a critical effect. No numerical values for occupational 
exposure limits are proposed. Whereas NEG adopts the document by consensus 
procedures, thereby granting the quality and conclusions, the authors are 
responsible for the factual content of the document. 
The evaluation of the literature and the drafting of this document on 
Occupational skin exposure to chemicals were done by Dr Anneli Julander, Dr 
Anders Boman, Prof. Gunnar Johanson and Prof. Carola Lidén at the Institute  
of Environmental Medicine, Karolinska Institutet, Stockholm. 
The draft versions were discussed within NEG and the final version was adopted 
by the present NEG experts on 6 March 2017. Editorial work and technical editing 
were performed by the NEG secretariat. The following experts participated in the 
elaboration of the document: 
 
NEG experts  
Gunnar Johanson  Institute of Environmental Medicine, Karolinska Institutet, 
Sweden 
Merete Drevvatne Bugge National Institute of Occupational Health, Norway 
Helge Johnsen National Institute of Occupational Health, Norway 
Nina Landvik National Institute of Occupational Health, Norway 
Anne Thoustrup Saber National Research Centre for the Working Environment, Denmark 
Helene Stockman-Juvala  Finnish Institute of Occupational Health, Finland 
Mattias Öberg  Institute of Environmental Medicine, Karolinska Institutet, 
Sweden 
Former NEG expert  
Tiina Santonen  Finnish Institute of Occupational Health, Finland 
Vidar Skaug  National Institute of Occupational Health, Norway  
NEG secretariat  
Anna-Karin Alexandrie 
and Jill Järnberg  
Swedish Work Environment Authority, Sweden 
 
This work was financially supported by the Swedish Work Environment 
Authority and the Norwegian Ministry of Labour and Social Affairs. 
All criteria documents produced by the Nordic Expert Group may be 
downloaded from www.nordicexpertgroup.org. 
 
 
 
 
Gunnar Johanson, Chairman of NEG  
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 Abbreviations and acronyms 
ACGIH American Conference of Governmental Industrial Hygienists 
AES atomic emission spectroscopy 
BAuA Bundesanstalt für Arbeitsschutz und Arbeitsmedizin (Federal 
Institute for Occupational Safety and Health)  
CLP classification, labelling and packaging of substances and mixtures 
DFG Deutsche Forschungsgemeinschaft (German Research Foundation) 
DMG dimethylglyoxime 
DNEL derived no-effect level  
EC3 estimated concentration to cause a 3-fold increase in draining 
lymph-node cell proliferative activity 
ECETOC European Centre for Ecotoxicology and Toxicology of Chemicals 
ECHA European Chemicals Agency 
ED10 minimum elicitation dose giving a reaction in 10% of sensitised 
subjects 
EU European Union 
GPMT guinea pig maximisation test 
HF hydrofluoric acid 
HRIPT human repeated insult patch test 
IARC International Agency for Research on Cancer 
ICP inductively coupled plasma 
IgE immunoglobulin E 
Kow octanol:water partition coefficient 
Kp permeability coefficient 
LLNA local lymph node assay 
MS mass spectrometry 
MW molecular weight 
NIOSH National Institute for Occupational Safety and Health 
OECD Organisation for Economic Co-operation and Development 
OEL occupational exposure limit 
OSHA Occupational Safety and Health Administration 
PBS physiologically buffered saline 
QSAR quantitative structure-activity relationship 
REACH Registration, Evaluation, Authorisation and Restriction of 
Chemicals 
ROAT repeated open application test 
SAR structure-activity relationship 
SCCS Scientific Committee on Consumer Safety 
SCOEL Scientific Committee on Occupational Exposure Limits 
TOCP tri-o-cresyl phosphate 
US United States 
UV ultraviolet 
 
 Selected skin sensitisers mentioned in this document.  
Abbreviation Chemical name, INCI a name and/or  
common trade name 
CAS no. 
– formaldehyde 50-00-0 
– isoeugenol 97-54-1 
BIT 1,2-benzisothiazolin-3-one; 
benzisothiazolinone 
2634-33-5 
CMIT (or MCI) 5-chloro-2-methyl-4-isothiazolin-3-one; 
methylchloroisothiazolinone 
26172-55-4 
CMIT/MIT  
(or MCI/MI) 
5-chloro-2-methyl-4-isothiazolin-3-one/ 
2-methyl-4-isothiazolin-3-one (3:1);  
methylchloroisothiazolinone/methyl-
isothiazolinone (3:1); Kathon™ CG 
55965-84-9 
DMFu dimethylfumarate 624-49-7 
HICC 4-(4-hydroxy-4-methylpentyl)cyclohex- 
3-enecarbaldehyde; hydroxyisohexyl  
3-cyclohexene carboxaldehyde; Lyral™ 
31906-04-4 
IPBC 3-iodo-2-propynyl butylcarbamate; 
iodopropynyl butylcarbamate  
55406-53-6 
MDBGN 2-bromo-2-(bromomethyl)pentanedinitrile; 
methyldibromo glutaronitrile 
35691-65-7 
MIT (or MI) 2-methyl-4-isothiazolin-3-one;  
methylisothiazolinone 
2682-20-4 
PPD p-phenylenediamine 106-50-3 
a INCI: international nomenclature of cosmetic ingredients.
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1. Introduction 
Occupational skin diseases represent up to 30% of the occupational diseases in 
Europe. The European Union Agency for Safety and Health at Work (EU-OSHA) 
has stated that skin disorders are the second most common occupational diseases 
in the EU, with chemicals being responsible for 80–90% of these (54). The most 
important exogenous risk factors for occupational skin diseases are exposure  
of skin to skin sensitising substances (contact allergens), skin irritants and wet 
work. Among the most frequently affected sectors and occupations are healthcare, 
hairdressing, cleaning, food processing, chemicals and metals industry, and 
construction work (39). 
Contact dermatitis (including both allergic and irritant contact dermatitis) is the 
most frequent occupational skin disease and is most commonly localised to the 
hands. The one-year prevalence of hand eczema in the general population is 10%, 
and it affects women more frequently than men due to differences in exposure 
(208). Hand eczema causes job loss, unemployment, severe suffering and is often 
chronic. Occupational skin diseases in the EU cost in excess of 5 000 million 
euros/year in lost productivity, treatment and compensation (33, 109). Very few 
scientific reports on costs related to occupational skin diseases have been 
published, among them references (25, 38, 41, 168). 
Contact dermatitis is also the most common skin disease caused by skin expo-
sure to chemicals. Other skin diseases or effects on skin which can sometimes be 
chemically induced include contact urticaria, photo-contact dermatitis, burns, 
acne and lichenoid reactions. 
Skin exposure to chemicals can also cause systemic effects and skin cancer 
(165). Arsenic, creosote and polycyclic aromatic hydrocarbons (PAHs) are known 
to cause skin cancer. Skin cancer will not be discussed further in this document.  
EU legislation imposing restrictions and other regulatory measures on some 
skin sensitisers has been successful. The most prominent examples are chromium 
(VI) in cement, nickel in prolonged contact with the skin, some preservatives and 
the biocide dimethylfumarate (DMFu). 
The present document on occupational skin exposure to chemicals is not a com-
prehensive review of the area, but rather an introduction to the field with emphasis 
on skin exposure assessment, skin sensitisation and prevention by exposure 
reduction. Information on contact allergy, contact dermatitis and prevention has 
been compiled from peer-reviewed original and review publications, and partly 
from text books. 
2. The skin and its function 
The skin is the demarcation between the body and the outside world and is 
essential for life in the relatively dry environment we exist in. The skin encloses 
and preserves vital substances and molecules in the body; most importantly, it 
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limits the loss of the water present in the body. It also protects against many 
external chemical and physical factors. 
2.1 Skin barrier function in relation to water and chemicals 
The skin consists of three layers: epidermis, dermis and subcutis (Figure 1). In  
the epidermis, which is composed of keratin cells (keratinocytes), it is possible  
to distinguish multiple layers where the horny layer (stratum corneum) is the 
outermost. The horny layer is 10–20 µm thick in most areas of the body and about 
10 times thicker on the soles and palms. The stratum corneum, by its structure, 
constitutes the actual water barrier. It is composed of flattened converted keratin 
cells, so-called corneocytes, which are filled with structural protein. The inter-
cellular space consists of a thin multilayer of lipids known as ceramides. Together 
with the corneocytes, these lipids form a virtually waterproof membrane around 
the body, often likened to a brick and mortar wall. Throughout the epidermis  
and stratum corneum there is, however, a slow diffusion of water acting as a 
plasticiser for the skin. This diffusion gives rise to a measurable evaporation of 
water from the skin surface, transepidermal water loss, which amounts to about 
0.5 litres per day (13). 
The human skin also serves as a relatively good barrier against exposure to 
chemicals in the environment. With the exception of a few toxins and contact 
allergens, chemicals found naturally in the environment rarely constitute a  
health hazard at dermal exposure. However, after the development of organic 
chemistry in the mid-1800s, many organic chemicals with dermal penetrating 
abilities and capacity to alter the properties of the skin barrier have been 
produced. A number of organic solvents are readily absorbed by the skin and 
 
Figure 1. The skin with its three layers and different organs. 
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cause intoxication. Other substances that are highly toxic at skin exposure are 
organic phosphorus compounds used as insecticides. Many substances have an 
effect mainly on the skin lipids, altering the skin barrier properties and facilitating 
passage of other chemicals. This may result in systemic toxicity as well as local 
skin effects (13). 
The driving force for diffusion across the skin barrier is the concentration 
gradient across the barrier. This means that higher concentrations of a harmful 
chemical result in higher flow rates across the skin barrier, causing more damage 
locally and systemically than more diluted chemicals. Nevertheless, one should 
not neglect exposures to products with low concentrations of chemicals such as 
mild irritants and contact allergens. Repeated or prolonged exposure may lead  
to the development of allergy (induction of skin sensitisation), allergic contact 
dermatitis (elicitation) or an irritant reaction. An injured skin is a poor barrier 
resulting in substances being absorbed to a greater extent. Exposure under 
occlusion, for example under a thick glove, can lead to increased uptake through 
increased hydration of the skin and reduced evaporation of the substance. The  
skin barrier itself is also impaired by occlusion. 
The efficacy of the skin barrier does not vary with gender or colour of skin. 
However, the skin barrier function may decline with age due to a general thinning 
of the skin over time. Disease or injury to the skin may affect the barrier 
negatively and atopic skin usually has a higher permeability.  
2.2 Additional skin functions 
The skin is normally a good barrier against microorganisms. Its surface carries 
resident and transient microorganisms that usually do not pose any health threat.  
If the skin surface is damaged by external influences or eczema, microorganisms 
can pass the barrier and give rise to infections locally or systemically (13, 37). 
The skin also provides a barrier against a variety of physical factors in the 
environment. One of the most obvious functions is to protect the body against 
external damage through the tensile strength of the cutis along with the padding 
(cushion) in the subcutaneous fat. The skin protects the body from ultraviolet 
(UV) and visible light by producing a dark pigment (melanin) in the melanocytes 
when exposed to UV light (13).  
The skin also protects against heat and overheating. One of the most important 
functions is the regulation of body temperature. The body can be cooled down 
through dilation of the small surface vessels in the skin and by sweating. Thus 
heat is transported from the body’s internal parts to the outer surface where it can 
dissipate. Conversely, skin blood flow is reduced at exposure to cold environments 
(13).  
In addition to the barrier function, the skin has a metabolising function. Several 
of the xenobiotic metabolising enzymes in the liver are also found in the skin 
(223, 230). Metabolic activation of chemicals (prohaptens) in the skin can result 
in formation of new or more potent skin sensitisers. This has been shown for a 
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range of chemicals, including fragrance substances (116). The skin is also the 
major site for vitamin D formation (13).  
Human skin has a signalling function, showing certain basic emotions through 
redness and paleness. It is also an important sensory organ. The dermis contains 
sensory cells that respond to physical stimuli such as pain, cold, heat, pressure, 
vibration and touch. This allows us to react and avoid hazards such as heat, pointed 
and sharp objects, and also to react positively to soft touches (13). 
3. Sources of skin exposure 
The skin is exposed to chemicals at contact with products, substances or materials. 
The contact can be intentional, as when washing the hands or using a cream, or 
unintentional usually from contaminated surfaces, accidental spills or splashes. 
The contact can also be due to processes that are less obvious, such as deposition 
of airborne compounds. There are many sources of skin exposure to chemicals. 
Typical examples are shown in Figure 2. 
Airborne exposure of the skin to skin sensitisers, skin irritants and photoactive 
substances, may result in dermatitis on the air-exposed areas but not on covered 
body parts. Airborne exposure to some chemicals may also result in significant 
skin absorption and systemic effects (Chapter 4).  
Contaminated surfaces in the workplace may be an important source of skin 
exposure, which is often overlooked. Surfaces may be contaminated by spillage, 
transferral by hands, tools or protective equipment, or from deposition of dust and 
the like.  
Intentional exposure includes not only makeup, perfume and hair dyes but  
also soaps and creams [defined as cosmetic products in the European Cosmetic 
Products Enforcement Regulation (64)]. Cosmetic products are generally con-
sciously applied onto the skin. The use of liquid soap in the workplace is often not 
considered when occupational exposure is discussed. This is important since such 
products generally contain sensitising preservatives and fragrance substances.  
 
Figure 2. Examples of typical sources of skin exposure to chemicals.  
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Release of chemical substances from solid items and materials may be signi-
ficant. Solids may release ions, compounds or particles by dissolution in sweat  
or other solvents or by friction against the skin. Both persistent contact and brief, 
repetitive contact may result in significant skin exposure. Typical examples are 
release of nickel ions from metal articles, chromium (VI) from leather articles, 
monomers from plastic, and rubber chemicals from rubber articles.  
As regards liquids, leakage or permeation through insufficient protective 
equipment is often overlooked. Liquids may consist of solutions, dispersions and 
solvents. Liquid on the skin may be wiped or washed off, smeared out, dry on  
the skin or evaporate. The amount of harmful constituents deposited on the skin 
surface depends on several factors including duration and frequency of exposure, 
and affinity of the liquid or its constituents. 
A model has been proposed by Schneider et al., who attempted to compile all 
processes leading to dermal uptake (189). The model’s primary objective was to 
allow assessment of all possible skin exposure routes to calculate the ultimate 
exposure metric, i.e. dermal uptake, for risk assessment. This might work for 
substances of concern for systemic uptake, but might not be the ideal solution for 
studying exposure leading to skin diseases. For this purpose, it would be more 
relevant to evaluate and standardise methods that measure the amount of a 
chemical or substance on the skin surface, since this is the most important metric 
for development of a skin disease (87). 
4. Dermal absorption 
In this document, dermal absorption (also called percutaneous or skin absorption) 
denotes the diffusion of a chemical from the outer surface of the skin through the 
skin and eventually into the systemic circulation. This contrasts dermal penetration 
which means diffusion across the outermost barrier, i.e. the stratum corneum, into 
the skin (160) and dermal permeation which denotes further diffusion into deeper 
skin layers. Many chemicals can more or less easily pass the skin barrier and thus 
raise concerns for systemic toxicity. Dermal absorption and penetration can be 
measured experimentally by various in vivo and in vitro methodologies. 
4.1 In vivo methods 
In vivo measurement of dermal absorption is advantageous, as the skin is intact, 
with retained metabolic capacity and blood supply to the dermis. The rat is the 
most commonly used species for in vivo testing. However, a wide variety of other 
species and strains have been used, including guinea pigs, mice, rats, dogs, mini-
pigs, pigs, monkeys and humans, and some hairless strains. 
In vivo studies in laboratory animals are preferably conducted as described by 
the Organisation for Economic Co-operation and Development (OECD) (160). In 
brief, the test sample is applied to a defined area (ideally about 10 cm2) of the skin 
and allowed to remain for a specified period of time, relevant to human exposure. 
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Throughout the experiment, the animal is housed individually in a metabolism 
cage from which excreta (and breath if volatile metabolites are expected) are 
collected. At the end of the exposure period, excess sample is removed from the 
skin surface. The animals are then euthanised and the amount of parent chemical 
and metabolite(s) in skin, carcass and excreta is determined. These data allow for 
an estimate of the total recovery of the test substance. 
Test chemical remaining in the skin after wash-off may disappear over time  
by diffusion to the environment, desquamation (shedding of the outer layers of  
the skin), ingestion during grooming, and by uptake to the systemic circulation. 
To avoid overestimation of the systemically absorbed dose, measures have to be 
taken to prevent the animal from grooming the site of application, and to prevent 
desquamated skin from falling into the urine and faecal collection systems. 
The dermal absorption of a test substance can be expressed as the percentage of 
the dose that passes the skin per unit time or, preferably, as an average absorption 
rate per unit area of skin, e.g. μg/cm2/h. 
In vivo studies with human volunteers must use a different experimental pro-
tocol, as the total recovery cannot be directly determined. The dermally absorbed 
dose is then determined indirectly, by comparison to a known dose, for instance 
the net uptake by inhalation exposure. The dermal absorption, or rather, the 
systemic dose via the dermal route, is calculated for example by comparing the 
urinary recoveries of the chemical and/or its metabolite(s) after the two exposure 
routes. Alternatively, the areas under the concentration-time curves (AUCs) in 
plasma or blood are compared. For examples of this approach, see e.g. studies by 
Johanson and colleagues (100, 101, 103, 104).  
A different approach to measure dermal absorption is microdialysis. A small 
probe equipped with a semipermeable hollow fibre is inserted superficially into 
the dermis, parallel to the skin surface. A physiological saline solution is slowly 
pumped through the fibre and allowed to equilibrate with the surrounding 
extracellular space. The solution is then retrieved and the concentration of the 
substance of interest can be measured. For overviews, see e.g. Anderson (7), 
Schnetz and Fartasch (190) and Stahl et al. (197). 
Human pharmacokinetic microdialysis has only been carried out for a few 
decades and there are limited data, mainly on pharmaceutical drugs, on dermal 
absorption using this technique. There are several difficulties in obtaining 
quantitative measures of the dermal absorption by microdialysis. A major problem 
is that concentration and not flux is measured. The concentration will depend not 
only on influx via stratum corneum but also on efflux via the blood stream. Other 
difficulties stem from the positioning of the probe (as the concentration tends to 
decrease with the distance from the skin surface), and from defining the exposed 
skin area.  
Tape stripping should also be mentioned here, as it is a convenient method to 
measure penetration into the skin. Tape stripping is further discussed in Section 
7.1.1.1. 
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4.2 In vitro methods 
In vitro, excised skin from experimental animals or humans is mounted in a  
so-called diffusion cell, where the test chemical is applied on the outer surface 
(apical side) of the skin. The inner (basal) side of the skin is held in close contact 
with a suitable receptor medium, usually physiologically buffered saline (PBS). 
Depending on the properties of the test substance, polyethylene glycol or other 
solubility enhancers may be added to the receptor medium. The diffusion cell  
may be static (Figure 3) or flow-through; the latter is more easily adapted for 
automation, i.e. online measurement or autosampling. An advantage of the in  
vitro methods is that toxic and skin damaging chemicals can be tested without  
risk of harming an animal or test person.  
As with in vivo studies, the exposure duration should be relevant for human 
exposure situations. The receptor fluid is sampled at defined time points through-
out the experiment and the concentration of the parent chemical as well as any 
significant metabolite(s) is determined by a suitable analytical method to determine 
the amount of test substance (including any significant metabolite) that has passed 
through the skin. At the end of exposure, excess sample is removed from the 
donor compartment by appropriate cleansing. The removed amount, the amount 
contained in the skin and the amount in the receptor fluid are determined to 
account for the mass balance. 
To calculate the dermal absorption rate, the concentration in the receptor fluid  
is translated to absolute mass by multiplying by the receptor volume. The absolute 
mass rate, i.e. the increase in mass with time during steady-state condition, is ob-
tained as the slope of the linear part of the mass versus time curve (“B” in Figure 
4). Finally, the unit absorption rate or flux is obtained by dividing the mass rate  
by the exposed skin area. For more detailed descriptions, see e.g. the OECD 
guideline (161). 
 
 
Figure 3. Static diffusion cell for dermal absorption studies in vitro. Reprinted from 
Johanson and Rauma (107). PBS: physiologically buffered saline. 
Donor compartment 
Skin piece 
Sampling outlet 
Receptor compartment containing PBS or 
other suitable medium 
Heated water compartment, connected to 
a thermostatted water bath 
Magnetic stirrer 
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Figure 4. Mass of chemical versus time in the receptor medium static diffusion cell.  
A: Lag time of skin penetration, B: Steady-state, the slope (dotted line) equals absorption 
rate, C: Absorption rate decreases (curve levels off), either due to back diffusion (limited 
solubility in receptor medium) or depletion at donor site. Reprinted from Johanson and 
Rauma (107). 
4.3 Structure-activity based methods 
Several regression equations have been developed that relate permeability 
coefficients (Kp) to easily obtained chemical properties, such as the octanol:water 
partition coefficient (Kow) and molecular weight (MW). The Kow is thought to 
represent the solubility and MW the size and, hence, diffusivity of the molecule  
in the skin. The regression equations are often of the form (146): 
log Kp = a + b × log Kow + c × MW 
The constants a, b and c are determined by fitting the equation to specific 
experimental data sets. One of the most commonly cited equations was developed 
by Potts and Guy (169): 
log Kp = – 2.72 + 0.71 × log Kow – 0.0061 × MW 
where Kp is expressed in cm/h. More complicated models have also been 
developed, e.g. the modified Guy (231), the Cleek and Bunge (32), the McKone 
and Howd (147), the modified Robinson (231) and the Frasch model (75). The 
United States National Institute for Occupational Safety and Health (US NIOSH) 
has developed an online skin permeation calculator that makes use of the Potts 
and Guy, the modified Robinson and the Frasch models (157). 
These equations generally work well within homologous series and structurally 
related chemicals, but are often unreliable outside that range. The error may be up 
to one or two orders of magnitude, compared to experimental data (107). 
Time 
 
M
as
s 
 
 9 
4.4 Factors affecting dermal absorption 
The dermal absorption rate (flux) is directly proportional to:  
- the concentration (more correctly the chemical activity, partial pressure  
or fugacity) of the chemical at the skin surface (assuming that the inner 
concentration is negligible), and 
- the permeability of the skin (expressed by Kp).  
The total amount of absorbed chemical is proportional to (in addition to 
concentration and permeability): 
- the exposed area (since Kp is expressed per area unit), and 
- the duration of exposure. 
Obviously, Kp depends on the properties of the chemical as well as those of the 
skin. Major properties of the skin that influence permeability are the thickness  
of the stratum corneum, and the temperature and degree of skin hydration. The 
thickness of the stratum corneum varies considerably between different species 
and locations on the body. In addition, the penetration tends to increase with 
temperature as molecules move faster, though this is only of minor importance  
as the skin temperature is fairly constant. However, increased body temperature, 
increased ambient air temperature and increased air humidity and skin occlusion 
all contribute to increased skin hydration and increased dermal blood flow, which 
in turn increases the penetration and absorption of chemical. Contact dermatitis 
and other adverse skin effects may also increase the systemic uptake (107). 
4.5 Dermal absorption of selected chemicals 
There are several reports on acute poisoning following skin contact with different 
types of chemicals such as hydrofluoric acid (HF) (24), 2,4-dinitrophenol (142), 
tetramethylammonium hydroxide (126, 164, 232), as well as paraquat (225, 235), 
pentachlorophenol (110) and other pesticides (see below). 
HF is a highly corrosive acid widely used in various etching and cleaning pro-
cesses. Skin contact with HF may, depending on concentration, area and duration, 
cause serious skin burns and life-threatening or lethal systemic toxicity (24, 204). 
Exposure of more than 1% of the body surface (i.e. approximately the palm of a 
hand) to concentrated HF may lead to systemic toxicity (86). 
Clothing may reduce or prevent chemical exposures, but may also prolong the 
exposure, if the clothes are soaked with chemical or if the chemical is trapped 
inside the clothes. The occluding effect of the clothes (especially gloves) may 
further enhance the systemic exposure (Section 4.4).  
Some important categories of chemicals for which significant dermal absorption 
has been shown are presented below. 
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4.5.1 Pesticides 
Acute poisoning with pesticides is a global public health problem especially in 
developing countries, and has been estimated to account for 300 000 deaths per 
year worldwide. Most deaths are caused by organophosphates, organochlorines 
and aluminium phosphide (82). 
Wester et al. studied the dermal absorption of paraquat in 6 volunteers. Between 
0.2% (hand) and 0.3% (leg, forearm) of the applied dose (9 µg/cm2) was absorbed 
in 24 hours, corresponding to a relatively low uptake rate of 30 ng per cm2 and  
24 hours (226). Yet, the dermal route has been implicated in serious paraquat 
poisonings (225, 235). Two female workers with massive skin exposure (2–3%  
of the body surface) to paraquat after spraying developed skin erythema, blistering 
and bleeding and later on systemic symptoms like dyspnoea (235). Wesseling et 
al. investigated 15 fatalities (all males) caused by paraquat. In 10 of the cases 
exposure had occurred via ingestion, whereas no apparent oral intake could be 
identified in the remaining 5. For 3 of the latter, the route was clearly dermal 
(225). 
Pentachlorophenol and other chlorophenols have a long history of use as pesti-
cides and disinfectants. Pentachlorophenol was banned in Sweden in 1978 (141), 
by the EU in 1991 (55) and by the Stockholm Convention in 2015 (200). It was 
widely used as a wood preservative and is still used in large quantities worldwide, 
the estimated annual production being 15 400 tonnes (98). Acute poisonings have 
occurred repeatedly e.g. in workers after dipping wood in pentachlorophenol liquid 
formulations, and in hobbyists after brushing pentachlorophenol onto logs (110). 
Riviere et al. measured the dermal absorption of dissolved pentachlorophenol  
ex vivo in pig skin flaps. Depending on formulation, between 8% (ethanol) and  
27% (water, ethanol, sodium lauryl sulphate (detergent) and methyl nicotinate 
(vasodilator)) of the applied pentachlorophenol (40 µg/cm2) passed the skin in  
8 hours (174). 
Aggarwal et al. (3) compiled dermal absorption data for pesticides (295 studies 
in total, covering 152 active substances, 19 formulation types and representative 
ranges of spray concentrations) obtained with human skin in vitro according to the 
OECD guideline (161) and using the European Food Safety Authority (EFSA) 
guidance worst-case assumption that all chemicals not remaining in the skin and 
the first two tape strips were absorbed (51). The compilations showed that the 
median percent absorbed active substance was 0.6% (95th percentile 5.2%, n = 250) 
for liquid concentrates, 0.3% (95th percentile 1.6%, n = 53) for solid concentrates, 
and 6.7% (95th percentile 32%, n = 446) for diluted formulations. No clear relation 
between percent absorbed and molecular weight or log octanol:water partition 
coefficients (log Kow) was seen (3). 
4.5.2 Phosphate triesters 
Several phosphate triesters are frequently utilised as flame retardants, plasticisers, 
stabilisers and additives in products such as floor polishes, lubricants and hydraulic 
fluids (195). In cats dermally exposed to tri-o-cresyl phosphate (TOCP), 48% of 
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the applied dose was recovered in urine and faeces within 10 days post-exposure 
(158). Neurological effects in dermally exposed European ferrets also indicated  
a high dermal absorption (201). Marzulli et al. reported a dermal absorption rate 
for TOCP of 0.18 μg/cm2/h (145). Applying the ECETOC (European Centre for 
Ecotoxicology and Toxicology of Chemicals) criteria (43) (Section 9.1) this would 
correspond to a systemic dose via skin of 72% of that inhaled at an occupational 
exposure limit (OEL) of 0.1 mg/m3. 
Tri-n-butyl phosphate (TBP) showed a high penetrating capacity in isolated 
human skin in vitro. The average steady-state absorption rate was 10.8 μg/cm2/h 
(145). Applying the ECETOC criteria, the dermal systemic uptake would be 
nearly 200% of that inhaled at an OEL of 2.2 mg/m3. 
In vitro, tris(1,3-dichloro-2-propyl) phosphate (TDCPP) was readily absorbed 
through skin from hairless mice and 39–57% of the applied dose was detected in 
the receptor fluid by 24 hours (94). 
Taken together, although few human skin exposure studies in vivo have been 
conducted (195), the above examples show that exposure to phosphate triesters 
via skin will result in significant systemic exposure. 
4.5.3 Organic solvents 
All organic solvents can more or less easily pass the skin. Several organic solvents 
may even cause acute toxic effects, including mortality, following skin exposure, 
as shown in animal experiments (222), and human deaths have been reported  
after accidental skin exposure, e.g. to 2-chloroethanol (83) [cited by the National 
Advisory Committee for Acute Exposure Guideline Levels for Hazardous 
Substances (NAC/AEGL) (159)]. 
The skin absorption is dependent on the physicochemical properties of the 
solvents; low molecular weight and high lipophilicity result in high solubility and 
mobility in the lipid phase of the stratum corneum. Chemicals with the highest 
dermal absorption rate are generally found in the group of amphiphilic organic 
solvents, e.g. glycol ethers. The combination of high lipid solubility and high 
water solubility means that there are no solubility barriers – neither in the intra-
cellular lipid phase of the stratum corneum, nor in the hydrophilic epidermis or 
the transfer into circulating blood. 
Johanson and Rauma reviewed experimental data on dermal absorption of  
165 substances, many of which are organic solvents. The review showed that 
quantitative information on dermal absorption was lacking for about one third  
of the substances. For those with quantitative data, a variety of species and 
experimental techniques had been used. There was a trillion-fold (1012) span in 
permeability coefficients (Kp) between all substances and a hundred thousand- 
fold (105) span between organic solvents. Moreover, for many chemicals with 
several experimental data sets on permeability, there was a huge intrachemical 
span, sometimes several orders of magnitude (107). 
Rauma et al. reviewed and analysed the dermal absorption of chemical vapours 
(mainly organic solvents) using experimental data and regression and pharmaco-
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kinetic models. Dermal contribution ratios, i.e. the amount absorbed through  
skin relative to the total uptake (skin plus inhalation), were calculated for 33 
chemical vapours. The ratios varied from approximately 0.0002 (i.e. 0.02% via 
skin) for vinyl chloride to 0.8 (80% via skin) for 2-butoxyethanol, with hydro-
philic chemicals having a higher ratio than lipophilic ones. Multiple regression 
analysis of the data suggested that the ratio is largely explained by the octanol: 
water partition coefficient (Kow), vapour pressure and molecular weight. The 
authors concluded that dermal absorption of chemical vapours needs more 
attention, as such exposures are common, data are scarce and few predictive 
models exist (173).  
Some organic solvents may act as dermal penetration enhancers, i.e. they 
increase the penetration (and absorption) of other chemicals. Thus, several aprotic 
organic solvents, such as dimethyl sulphoxide, dimethyl formamide, dimethyl 
acetamide as well as several terpenes and glycol ethers, are used as penetration 
enhancers in various situations (85, 187). Even water may act as a penetration 
enhancer of organic solvents (104). 
4.5.4 Metals 
Systemic uptake of metals via skin has previously not been considered to be  
of major concern. However, absorption of metal ions was shown already in the 
1960s in experimental animals. 
Skog and Wahlberg studied the dermal absorption of several metal ions in 
guinea pigs using radioactive isotopes and scintillation counting. For mercury 
(Hg2+), the amount absorbed in 5 hours, calculated from the reduced radioactivity 
at the exposure site, varied between 1.7% and 4.5% (depending on pH and con-
centration) of the applied amount. The 5-hour absorption of cobalt, zinc and silver 
ions was lower and generally below 1%. Absorption through skin was confirmed 
by elevated radioactivity in various organs of the test animals (196). The same 
group also studied the absorption of these metal ions through guinea pig and 
human abdominal skin in vitro. The absorption rate through human abdominal 
skin (autopsy material, washed with soap and water and frozen before use) during 
the first 4 hours of exposure to 0.085 M cobalt chloride was 38 nmol/cm2/h  
(2.2 μg Co/cm2/h). The in vivo dermal absorption rate in guinea pigs was in the 
same range as the in vitro dermal absorption rate reported for humans (221). 
Skin absorption following exposure to elemental metals has also been 
demonstrated. Thus, Scansetti and co-workers showed that experimental exposure 
of hands only to hard metal powder (tungsten carbide with 5–15% cobalt) caused 
elevated levels of cobalt in the urine of the test persons (181). Using the Scansetti 
data (181), Palmen calculated the 24-hour cumulative uptake (one hand exposed) 
to 21 μg Co and the dermal absorption rate to 33 ng Co/cm2/h (163). Applying  
the ECETOC criteria (44) the calculated uptake was 66 μg, or 18% of the amount 
absorbed during 8-hour inhalation exposure to 50 μg Co/m3. 
Cobalt absorption through the skin was studied in volunteers immersing both 
hands in a used coolant solution (containing 1 600 mg Co/l) for 1 hour. The total 
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24-hour excretion was calculated from analysis of cobalt in urine (140). From the 
results, a dermal absorption rate of 1.4 ng Co/cm2/h was calculated (163). 
Larese et al. applied powders of nickel, cobalt and chromium (5 g/100 ml) in 
synthetic sweat (pH 6.5) on human skin mounted in Franz diffusion cells. Analysis 
by several methods [electrothermal atomic absorption spectroscopy, differential 
pulse polarography, differential pulse voltammetry, inductively coupled plasma 
atomic emission spectroscopy (ICP-AES)] confirmed the presence of ionic nickel 
and cobalt, but not chromium (< 0.1 mg/l) in both donor and receptor medium 
after 24 hours. The permeation fluxes were determined to 12 ng/cm2/h (nickel) 
and 17 ng/cm2/h (cobalt). These experiments thus showed that metallic nickel and 
cobalt can be oxidised when suspended in synthetic sweat and that measurable 
amounts of the ions can pass through human skin. According to the authors, 
chromium would probably need stronger oxidising conditions (122).  
4.5.5 Nanomaterials 
Numerous studies have examined the dermal penetration of various types of 
nanomaterials, mostly by different microscopic imaging techniques. The studies 
consistently show that an overwhelming proportion of the topically applied nano-
material remains on the surface or in the outermost layers of stratum corneum. 
Furthermore, nearly all studies have failed to demonstrate penetration beyond the 
epidermis. A limitation with these studies is that they are qualitative rather than 
quantitative in nature, and detection limits are not available (102).  
A few studies have used sensitive analytical methods to measure absorption 
through skin in vitro with diffusion cells, mainly by using metal-containing nano-
particles and analysis by inductively coupled plasma-mass spectrometry (ICP-
MS). These studies are summarised in Table 1. The amount that passes through 
human skin in vitro ranges from 0.0007% (silver) to 0.5% (gold) per 24 hours of 
the dermally applied dose. Many factors besides composition, size, shape and 
surface charge (zeta potential) may influence the results, including coating, agglo-
meration, concentration of nanomaterial in donor medium, composition of donor 
and receptor medium, pH and design of diffusion cell. Two major factors may 
Table 1. Estimates of absorption of nanoparticles through intact skin in vitro. 
Main 
constituent 
Size 
(nm) 
Zeta 
potential 
Species Applied 
dose 
Recovery in 
receptor medium 
after 24 hours 
Fraction 
absorbed after 
24 hours (%) 
Ref. 
Gold 13 ns Human 45 µg/cm2 214 ng/cm2       0.5 (71) 
Gold 18 × 40 + Mouse 50 µg a 60 ng b       0.1 a (127) 
Gold 18 × 40 - Mouse 50 µg a 360 ng b       0.7 a (127) 
Silver 25 ns Human 70 µg/cm2 0.46 ng/cm2       0.0007 (123) 
Titanium 
dioxide 
20–70 ns Human 60 µg/cm2 < 42 ng/cm2    < 0.07 (42) 
Zinc oxide 200 ns Human 20 µg/cm2 < 32 ng/cm2    < 0.16 (42) 
a Unknown area.  
b After 48 hours.  
ns: not stated.  
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contribute to falsely high values: disruption of the barrier during preparation and, 
perhaps more importantly, dissolution of metal from the nanomaterial prior to 
absorption.  
Larese Filon and colleagues recently performed a thorough review of the dermal 
penetration and permeation (i.e. the movement to deeper skin layers) of nano-
particles (124). In contrast to the above reasoning on diffusion, they concluded 
that experimental data allows for a differentiation by size in that nanomaterial: 
≤ 4 nm can penetrate and permeate intact skin, 
4–20 nm can potentially permeate intact and damaged skin, 
21–45 nm can penetrate and permeate damaged skin only, 
> 45 nm can neither penetrate nor permeate the skin.  
The studies presented in Table 1 and the above size categories suggested  
by Larese Filon et al. (124) are at odds with theoretical calculations made by 
Watkinson et al. (224). Thus, based on the Potts and Guy equation, Watkinson et 
al. calculated permeability coefficients (Kp) for the diffusion through intact skin 
of nanoparticles, assuming spherical shape, a density of 1 g/cm3 and a log octanol: 
water partition coefficient (log Kow) of 2. The predicted Kp values were 6 × 10
-4,  
2 × 10-17 and 0 cm/h for 1, 2 and 5 nm nanoparticles, respectively. For comparison, 
the Kp values for neat chemicals with a skin notation (Section 9.1) are typically 
between 0.1 and 10-4 cm/h (107). Using the equation of Magnusson et al. (144)  
[= eq. 2 in Watkinson et al. (224)], the predicted maximum flux values were cal-
culated to 0.34, 2 × 10-28 and 0 µg/cm2/h, compared to typically 0.1–104 µg/cm2/h 
for chemicals with a skin notation. These calculations suggest that nanoparticles, 
except the very smallest ones of 1 nm, are too large to permeate intact skin by 
diffusion.  
The nanoparticle surface charge (zeta potential) may also influence dermal 
penetration and permeation; however, seemingly opposite results have been 
reported. For example, Ryman-Rasmussen et al. reported deeper penetration into 
the stratum corneum of positive compared to negative quantum dots (QDs) (178), 
whereas Lee et al. measured up to 6-fold lower percutaneous absorption of positive 
compared to negative gold nanorods (127). Kim and co-workers, using cultured 
human colon carcinoma cells and mathematical modelling, showed that positively 
charged drug-carrying gold nanorods had higher uptake and dissociation by viable 
cells, whereas negative nanorods diffused faster (118). Rancan et al. similarly 
found that despite partial particle aggregation, silica particles were taken up by 
skin cells in a size-dependent manner and that positive particles had a higher 
cellular uptake rate. On the other hand, the positive particles tended to aggregate, 
lowering the uptake rate (171). Overall, there appears to be a complex relation 
between size, surface charge, pH, aggregation and dermal penetration and 
permeation. 
For pharmaceutical drugs and other chemicals, the follicular route has pre-
viously been considered to be of minor importance. However, it has been shown 
that the skin penetration rate of various drugs is significantly lower in hairless 
than in hairy rodents, that the rate correlates with the follicle density and that it 
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can be lowered by blocking the follicular openings [for references see e.g. Rancan 
and Vogt (172)]. There are several reasons for a potential importance of this  
route also for nanomaterials: large contact area and large storage volume of the 
follicles, well developed capillary network, and less developed stratum corneum 
(compared to the skin surface). Thus, once accumulated in the follicular canal, 
nanoparticles might more easily translocate across the stratum corneum and reach 
the lymph and blood circulation. Skin penetration of nanomaterial via the hair 
follicles has therefore received considerable attention.  
The size categories suggested by Larese Filon et al. (124) (see above) still need 
to be confirmed. In any case, smaller nanoparticles are expected to have a greater 
ability to penetrate through the skin than bigger ones. In real-life conditions, the 
dermal absorption through intact skin of larger nanoparticles (at the 100-nm end) 
is likely zero or insignificant. The absorption of small-scale nanoparticles (at the 
1-nm end) may be a concern. Still it is likely very low compared to, e.g., organic 
solvents. 
A remaining concern, especially for metal nanoparticles, is that of dissolution, 
e.g. in sweat, and subsequent skin penetration of the dissolved molecules/ions.  
It is well known that metal and metal oxide powders, once placed in biologic 
media, can release metal ions (149-151). Experiments by Larese Filon et al. have 
demonstrated that metallic nickel and cobalt can be oxidised when suspended in 
synthetic sweat (122). Release of metal ions may not only enhance the penetration 
and permeation of the metal but also result in a changed tendency to form aggre-
gates and an increased sensitising potential (124). 
5. Skin sensitisers 
Contact allergy is mediated by antigen-presenting cells in the epidermis 
(Langerhans cells), by antigen-specific T-cells, and cytokines. Contact allergy 
(also called Type-IV reaction or delayed hypersensitivity) is a type of allergy 
distinct from immunoglobulin E (IgE)-mediated allergy in asthma and rhinitis. 
Skin exposure to contact allergens may cause induction of contact allergy, and  
re-exposure of a sensitised individual or animal to the substance may result in 
elicitation of allergic contact dermatitis or a positive test reaction (Figure 5). 
Allergic contact dermatitis is the clinical disease caused by skin exposure to skin 
sensitising substances (contact allergens). The dose sufficient for induction of 
contact allergy is generally larger than the dose sufficient for elicitation. A 
sensitised individual has to avoid further exposure to the substance to avoid 
allergic contact dermatitis. Contact allergy is life-long, whereas allergic contact 
dermatitis may clear up if skin exposure to the substance is avoided (177). 
Figures on the prevalence of contact allergy are generally based on results  
from diagnostic patch testing of patients with dermatitis, done in dermatology 
clinics (167, 218). The prevalence of contact allergy is generally significantly  
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Figure 5. The two phases of skin sensitisation: induction of contact allergy, and, upon  
re-exposure, elicitation resulting in allergic contact dermatitis (Midander K and Yazar K).  
higher among dermatitis patients than in the general population (Table 2). Only a 
few large studies of contact allergy in the general population have been performed, 
see e.g. references (40, 121, 209). Contact allergy is estimated to occur in approxi-
mately 20% of the adult general population in Europe (40, 209). Children are also 
affected by contact allergy, but less frequently (121). The prevalence figures differ 
between studies, possibly depending on population selection, exposure and patch 
test technique. 
There are large differences between women and men for some allergens, and 
between certain occupational groups. There are also regional differences in pre-
valence of contact allergy. These differences are related to differences in exposure, 
particularly owing to occupational exposure and use of consumer products. 
More than 4 000 chemical substances have until now been identified as skin 
sensitisers. These are organic and inorganic substances with a molecular weight 
below 1 000 Da, often below 500 Da (74). 
The most frequent causes of contact allergy and allergic contact dermatitis are 
metals, preservatives, fragrance substances (perfumes), chemicals in plastic and 
rubber, and hair dyes. Some potent skin sensitisers may induce sensitisation by 
contact on single occasions, such as epoxy resins, some preservatives, some hair 
dye substances, and experimental allergens e.g. dinitrofluorobenzene (DNFB) and 
dinitrochlorobenzene (DNCB). Also less potent sensitisers such as nickel and 
many fragrance substances frequently cause contact allergy and dermatitis because 
exposure is difficult to avoid. Repeated exposure to the sensitiser, impaired skin 
barrier like in dermatitis, and occlusion of the skin are other factors that increase 
the risk of sensitisation and dermatitis (170, 177).  
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Guidance on how to evaluate human and animal data on skin sensitisation and 
set specific concentrations limits according to the CLP Regulation (EU regulation 
on classification, labelling and packaging of substances and mixtures) is available 
(50). 
Table 2. Prevalence of contact allergy and risk occupations. Examples of some of the 
most frequent skin sensitisers included in the European or Swedish baseline series for 
patch testing. 
Substance Property, 
presence  
or use,  
examples 
Prevalence (%) a  Occupational groups 
frequently affected by 
contact allergy, non-
exhaustive list (39) 
General population 
in 5 EU countries 
2008–2011 (40) 
Dermatitis 
patients in  
Sweden 2009 (66) 
Nickel  Metal  14.5  
m: 5.2; f: 22.2 
19.6  
m: 7.0; f: 26.7 
Cleaners, electronics 
workers, hairdressers, 
mechanics, metal 
workers 
Cobalt  Metal  2.2  
m: 1.1; f: 3.0 
5.8  
m: 3.0; f: 7.3 
Construction workers, 
dental technicians,  
hard metal workers 
Fragrance  
mix I b 
Perfumes,  
in cosmetics, 
chemical products 
0.9  
m: 0.5; f: 1.3 
5.6 Beauticians, 
hairdressers 
Chromium Metal,  
in cement,  
leather 
0.8 5.1 Construction workers, 
leather workers, tile 
setters 
Colophony Rosin,  
adhesive, 
soldering flux 
0.9  
m: 0.4; f: 1.4 
3.0 Electronic workers,  
metal workers, 
musicians 
Form-
aldehyde 
Synthesis, 
preservative 
0.4 2.7  
m: 1.9; f: 3.2 
Beauticians, cleaners, 
healthcare workers, 
metal workers 
Fragrance  
mix II c 
Perfumes,  
in cosmetics, 
chemical products 
1.9 2.3 Beauticians, 
hairdressers 
p-Phenylene-
diamine  
Dye, hair dye 
substance 
1.0 2.3  
m: 1.0; f: 3.0 
Hairdressers 
CMIT/MIT  Preservative, 
biocide 
0.5 2.1 Hairdressers, metal 
workers, painters 
Thiuram mix In rubber products,  
biocide  
0.5 1.7 Cleaners, construction 
workers, health care 
workers, rubber 
industry workers 
Epoxy resin Plastic chemical 0.9 1.1  
m: 1.8; f: 0.7 
Construction workers,  
tile setters 
a Presented by gender if significant difference; m: male, f : female. 
b Mixture consisting of 8 fragrance substances. 
c Mixture consisting of 6 fragrance substances. 
CMIT/MIT: methylchloroisothiazolinone/methylisothiazolinone (3:1), EU: European Union. 
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5.1 Metals 
5.1.1 Nickel 
Nickel (Ni) is used in numerous alloys and coatings, and in chemical compounds. 
It is used in articles for occupational and private use, many of which may come 
into contact with the skin. Two thirds of the nickel produced is used in stainless 
steels. Stainless steels contain iron, chromium and nickel and are produced in 
many qualities for different applications. Stainless steels are relatively resistant  
to corrosion, due to the formation of a thin inert film of chromium oxide on the 
surface. Nickel release from stainless steel at contact with skin is generally low, 
and most stainless steels are unlikely to cause nickel allergy (131, 133). 
Nickel is the most frequent cause of contact allergy (Table 2). Based on a recent 
study in 5 EU countries, it is estimated that approximately 14% of the adult 
general population (5% men, 22% women) is allergic to nickel (40). In a study in 
Sweden, 20% of the dermatitis patients (7% men, 27% women) were allergic to 
nickel (66). The lower prevalence in men is due to differences in exposure. The 
prevalence figures vary considerably between countries and over time, depending 
on differences in exposure, selection and other factors (78). About 30–40% of 
nickel-allergic individuals develop hand eczema which may become chronic (133). 
Occupational nickel dermatitis occurs in electronics industry workers, metal 
workers, hairdressers, car mechanics, construction workers, cleaners, hospital 
workers, cashiers and many other occupations (131). 
Nickel allergy is often associated with jewellery and other items in prolonged 
contact with the skin. The former EU Nickel Directive which now is part of the 
REACH legislation (EU regulation on Registration, Evaluation, Authorisation and 
Restriction of Chemicals), entered into force in the year 2000 (60). It restricted 
nickel release from certain consumer items intended for direct and prolonged 
contact with the skin (Section 9.3.1). Subsequently, nickel allergy has started to 
decline in European countries where there has been compliance with the regulation 
(78, 214). Despite the regulation, nickel is still the most frequent cause of contact 
allergy in Europe. One important reason is that also contact of relatively short 
duration with items such as handles, keys, coins, and tools cause nickel exposure, 
allergy and dermatitis.  
Methods to quantify skin exposure to nickel have been developed (Section 7.1). 
Knowledge on levels of skin exposure in different occupations will contribute to 
improved risk assessment and prevention. The dimethylglyoxime (DMG) test 
(Section 7.1.1.4) for nickel ions is a useful spot test for detecting nickel exposure 
and initiating exposure reduction measures at the workplace (114, 117, 212). 
5.1.2 Chromium 
Chromium (Cr) exists mainly in oxidation states 0, II, III and VI. Chromium has 
been used since the 19th century in leather tanning, alloys and platings. Chromium 
in different oxidation states and compounds is also used in anticorrosive paints, 
lacquers, wood preservatives and stainless steel, and has numerous other applica-
tions. Metallic chromium (Cr 0) is generally not considered sensitising, due to the 
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formation of a thin layer of chromium oxide on the surface. Cr VI is the most 
potent sensitiser, and chromium compounds – especially Cr VI compounds – have 
the capacity to induce sensitisation and elicit contact allergy. Cr III is used for 
leather tanning, but may be oxidised to Cr VI in the products. Cr VI was first 
detected in cement in 1950 (29, 133, 194).  
In Europe, 1–2% of the general adult population, and approximately 6% of 
dermatitis patients are allergic to chromium. Allergy to chromium was previously 
more frequent among men, but the gender difference has diminished during the 
last decade. The prevalence has decreased in men as a result of the restriction of 
chromium in cement in Nordic countries in the beginning of the 1980s and since 
2005 in the EU (61) (Section 9.3.1). There are strong indications that chromium 
allergy has increased in women during recent years due to exposure to chromium 
in leather (Cr VI and possibly Cr III) (29, 213). This has resulted in a restriction of 
Cr VI in leather in the EU, which entered into force in 2015 (58) (Section 9.3.1). 
5.1.3 Cobalt 
Cobalt (Co) is used in rechargeable batteries, hard metals, pigments, glass and 
glaze, paint and putty, magnetic materials, catalysts, dental alloys and orthopaedic 
implants, and cosmetics. Cobalt is a frequent cause of contact allergy. In Europe, 
1–2% of the general adult population and approximately 6% of the dermatitis 
patients are allergic to cobalt. Workers in the hard metals industry, electronics 
industry, construction workers and dental technicians handle cobalt. Workplace 
studies and studies based on patient materials have shown higher prevalence of 
cobalt allergy among these workers than among people with other occupations, 
the general population or dermatitis patients (111, 134).  
Allergy to cobalt is often seen together with allergy to nickel or chromium, but 
in half of the cases, allergy to cobalt is solitary (132). Concomitant exposure to 
cobalt and nickel is often assumed to occur, but is less likely today due to efficient 
refining. Little is known about sources of skin exposure to cobalt, and what causes 
cobalt allergy, except in the occupations with obvious exposures. A spot test for 
cobalt has recently been introduced for application in dermatology, and it will 
hopefully be useful in the search for sources of exposure (117, 210). 
5.2 Preservatives and biocides 
Preservatives are used to prevent products from being destroyed by micro-
organisms. The use of preservatives is increasing and new preservatives and areas 
for application are introduced. All preservatives in use have the ability to cause 
skin sensitisation; some of them are categorised as extremely potent skin 
sensitisers (128). Preservatives in cosmetics (including liquid soaps and creams 
for occupational use), paints and metalworking fluids come into contact with the 
skin and cause allergy and contact dermatitis (80, 130, 227). 
Contact allergy to preservatives as a group is seen in 12% of dermatitis patients 
in Denmark (192) (Figure 6). Methylchloroisothiazolinone/methylisothiazolinone 
(3:1) (CMIT/MIT, also known as MCI/MI, Kathon CG®), methyldibromo glutaro-
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nitrile (MDBGN), and several formaldehyde releasers are substances which have 
caused a rapid and alarming increase in contact allergy and dermatitis in recent 
decades. MIT on its own was introduced in chemical products around 2000 and in 
cosmetics in 2005; this has resulted in an ongoing epidemic of contact allergy to 
MIT. Benzisothiazolinone (BIT) and other sensitising isothiazolinones are also 
used in chemical products. MIT and BIT are both now used in almost all indoor 
paints (191). Parabens do not frequently cause contact allergy. Some preservatives 
have been restricted or banned in cosmetics to reduce the risk of skin sensitisation, 
while there are no restrictions on preservatives in paints, metalworking fluids or 
detergents (Section 9.3.1). 
Biocides are used to prevent harm to human health or property caused by 
animals, plants or micro-organisms, including viruses. The main groups of bio-
cidal products are disinfectants, preservatives, pest control, and other products. 
CMIT/MIT, MIT, BIT and other frequently used preservatives are used also as 
biocides. Chlorothalonil is a highly toxic, broad spectrum fungicide used in wood 
protection, agriculture, paints, etc. It is an extremely potent skin sensitiser (27).  
 
 
Figure 6. Frequency of contact allergy to preservatives in patch-tested dermatitis patients 
(n = 23 138) in Denmark 1985–2013. “Preservatives”: contact allergy to at least one 
preservative. Based on Schwensen et al. 2015 (192).  
CMIT/MIT: methylchloroisothiazolinone/methylisothiazolinone (3:1),  
IPBC: iodopropynyl butylcarbamate, MDBGN: methyldibromo glutaronitrile. 
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5.3 Plastic and rubber chemicals  
Epoxy resins are well known to cause severe occupational contact allergy. The 
monomer is the main allergen in epoxy of the bisphenol-A type (bisphenol A 
diglycidyl ether also known as DGEBA or BADGE) (1). Besides epoxy resins, 
phenol formaldehyde resins, acrylates and some diisocyanates [e.g. methylene-
bis(phenyl isocyanate) (MDI), hexamethylene diisocyanate (HDI), toluene di-
isocyanate (TDI)] are common contact allergens in thermosetting plastics, several 
of which are potent skin sensitisers (76, 206). Thermosetting plastics are used in 
many areas in workplaces, but also in consumer products. Large volumes are used 
in the construction industry, the furniture industry and in printing. Composite 
materials, paints and coatings are large-volume products. Small volumes of 
acrylates are used in dentistry, in orthopaedic surgery as bone cement, for wound 
sealing, and by beauticians for artificial nails and lengthened eyelashes (52, 176).  
Work with thermosetting plastics still causes contact allergy, but the problem is 
not as prevalent as in the 1970s. Work environment regulations (Chapter 9), new 
knowledge about the substances’ skin sensitising potential and ability to permeate 
through glove materials contributed to the improvement. It is generally considered 
that workers in industrial settings are better protected than other workers. New 
applications and lack of knowledge about risks and regulations have caused out-
breaks of allergy to epoxy in workers involved in pipe relining, and to acrylates  
in “nail artists” and previously in dental workers (10, 52, 70). 
Contact with rubber products may cause two types of allergy: contact allergy 
and IgE-mediated allergy from natural rubber latex (also called latex allergy). 
Hundreds of chemicals are used to manufacture rubber products. Thiurams, 
mercapto substances, derivatives of p-phenylenediamine (PPD), and carbamates 
are known skin sensitisers with different functions in rubber (20, 81). Several 
chemicals used in the rubber industry are also used for other applications, e.g. as 
biocides in paints, glues and metalworking fluids. Rubber gloves are a frequent 
cause of contact allergy to rubber chemicals. Boots, other protective equipment, 
hoses, gaskets, tires, etc. are sources of rubber allergy. It is often difficult to know 
which rubber chemicals are present in products, since ingredient labels are lacking. 
It may likewise be difficult to tell whether products are made of rubber or plastic.  
Latex allergy mainly affected health care personnel in the 1980s and 1990s. 
Initial symptoms were contact urticaria of the hands, sometimes also rhinitis and 
asthma, with a risk of developing anaphylactic shock (5). Latex allergy is less 
frequent now that the use of powdered latex gloves has decreased. Latex allergy 
will not be further discussed.  
5.4 Fragrance substances 
Contact allergy to fragrance substances in cosmetics and chemical products is 
common, affecting at least 16% of dermatitis patients in Europe, as shown by 
diagnostic patch testing with the very limited number of fragrance patch test 
substances used (currently 15 fragrance substances in the European baseline 
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series) (220). Sensitisation to fragrance substances is considered most often to be 
caused by cosmetic products such as perfumes and deodorants. Exposure to the 
same substances in soaps, creams, detergents and other products in the workplace 
and in consumer products causes dermatitis in sensitised individuals. Examples  
of occupational groups with work-related allergy to fragrance substances are 
beauticians, cleaners, hairdressers and metalworkers (35). 
More than 2 500 substances are used as fragrance ingredient in cosmetics. A 
recent risk assessment of fragrance allergens by the EU Scientific Committee on 
Consumer Safety (SCCS) (184) concluded that more than 100 substances had 
such skin-sensitising properties that they should be identified by name on the 
label. This number far exceeds the current 26 substances that must be named on 
cosmetics packaging (220). In addition, SCCS listed 11 substances of special 
concern, for which maximum concentrations should be set. The substances were 
categorised as established contact allergens in humans based on patch test data 
(n = 82), established contact allergens in animals (n = 19) or likely contact 
allergens based on structure-activity relationships (SARs) and limited human  
data (n = 26). Special concern was assigned to substances with a high number of 
reported cases (n > 100). The SCCS also concluded that three substances, hydroxy-
isohexyl 3-cyclohexene carboxaldehyde (HICC), atranol and chloroatranol, should 
not be present in cosmetic products (184, 220). The European Commission has 
decided to ban HICC, atranol and chloroatranol in cosmetic products and has 
proposed restrictions and labelling requirements in line with the SCCS opinion 
(59, 128). 
5.5 Hair dyes  
p-Phenylenediamine (PPD) is the most well-known hair dye and has been used for 
more than a century. It is an extremely potent skin sensitiser. Many other potent 
sensitisers have been introduced in hair dyeing. Oxidative (also called permanent, 
semi-permanent, etc.) hair dye products generally contain several potent skin 
sensitisers. Resorcinol, toluene-2,5-diamine and m-aminophenol are the most 
frequently used sensitisers in hair dyes in Sweden, Denmark and Germany, while 
the use of PPD is more frequent in Spain and the US (34, 88, 120, 233). 
Up to 5% of dermatitis patients and 30% of hairdressers with dermatitis in 
Europe are allergic to PPD. Hair dyeing is increasingly popular and contact allergy 
to hair dyes is increasing. The allergy results in acute dermatitis on the face, scalp, 
and neck among consumers, and hand eczema among hairdressers. PPD is the 
only hair dye substance regularly used in diagnostic patch testing. The prevalence 
of contact allergy to other hair dye substances is thus largely unknown (219). 
The SCCS and its predecessors have performed risk assessments of more than 
100 hair dye substances, as part of the European Commission hair dye strategy for 
assessment of potential genotoxicity or mutagenicity (182). A large number of 
substances have been allowed, restricted or banned. The SCCS also assessed the 
skin sensitising potency, based on animal data, and concluded that 56 of 114 hair 
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dye substances are skin sensitising, and 36 of them are potent sensitisers (128, 
185). 
Some hair dye substances are absorbed through the skin and may increase the 
risk of cancer. Occupational exposure as a hairdresser or barber is classified by 
the International Agency for Research on Cancer (IARC) as probably carcino-
genic to humans (Group 2A) (95) and o-toluidine as carcinogenic to humans 
(Group 1) due to its association with cancer of the urinary bladder (96). In  
Europe, o-toluidine and several other aromatic amines are banned as ingredients 
in cosmetics (64). However, recent studies have detected o-toluidine in hair dye 
products, and haemoglobin adducts of o-toluidine in blood from hairdressers (4, 
108). Some of the most well-known hair dye substances (PPD, resorcinol, and 
toluene-2,5-diamine) are classified by IARC as Group 3 (not classifiable as to its 
carcinogenicity to humans) (97). 
5.6 Other 
Several contact allergens can be found in natural products. The most commonly 
identified is pine resin or rosin derived from coniferous trees. Other natural 
sources of contact allergens are chemicals in various plants among which some 
are known to be very potent skin sensitisers. Some organic solvents of natural 
origin have sensitising properties, such as turpentine, limonene and other terpenes. 
It is not the solvent itself that is considered allergenic but oxidation products 
formed upon storage with access to oxygen or air (35, 89, 115). 
Several pharmaceutical drugs are potent skin sensitisers. They are usually not  
a problem when used for peroral treatment but may be an occupational hazard 
during manufacturing, handling and dispensing, by direct skin contact, airborne 
exposure of the skin or by inhalation. Examples of skin sensitisers are nitro-
glycerine used for angina pectoris, omeprazol for gastric ulcer, clonidine for 
hypertension, neomycin and several other antimicrobial drugs for topical anti-
microbial treatment (23). 
Spices as well as many other plants contain contact allergens and cause contact 
allergy in many occupations including chefs, bakers, food industry workers and 
food handlers (166). It has been suggested that enzymes in laundry detergents may 
cause dermatitis (either by irritancy or contact allergy), though this outcome is 
probably rare, and the mechanism has not been confirmed (16, 21).  
6. Skin irritants and corrosives 
According to the international chemicals regulations [GHS (Globally Harmonized 
System of Classification and Labelling of Chemicals) and CLP], skin irritation 
means the production of reversible damage to the skin following the application 
of a test substance for up to 4 hours, and skin corrosion means the production of  
a corresponding irreversible damage to the skin. Substances and mixtures are 
classified and subcategorised as skin irritants and corrosives based on data from 
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humans and non-human species (63, 215). Guidance on how to evaluate data and 
set specific concentrations limits according to the CLP Regulation is available 
(50).  
6.1 Wet work 
Wet work is an important and very common risk factor for hand eczema due to 
skin irritation (irritant contact dermatitis), particularly in subjects with previous  
or present atopic dermatitis. Prolonged or repeated contact with water, detergents, 
fresh food, organic solvents and other chemicals in liquid form is considered as 
wet work. Gloves can offer protection, but may also cause skin irritation (8, 9, 
148).  
According to the Federal Institute for Occupational Safety and Health (Bundes-
anstalt für Arbeitsschutz und Arbeitsmedizin, BAuA) in Germany, “Activities 
during which workers spend a considerable portion of their working time in a  
wet environment or wear liquid-proof gloves or wash their hands frequently or 
intensively count as wet work”. Exposure factors considered are thus duration, 
frequency and intensity. The use of protective gloves for more than 2 hours is also 
considered as wet work (19).  
6.2 Organic solvents 
Organic solvents have a range of local dermal effects (187). One very conspicuous 
but non-irritant reaction is a whitening effect on the skin, which may occur after a 
single exposure. The whitening is attributed to conformal changes in the lipids on 
the skin.  
Repeated skin exposure to organic solvents often leads to irritant contact derma-
titis. The solubility of lipids in organic solvents means that both lipids on the skin 
surface and intercellular lipids are extracted from exposed skin. An increase in 
transepidermal water loss generates a subsequent inflammatory response in the 
skin, leading to eczema. Structural changes in the cells in the skin have also been 
demonstrated already after a few minutes of solvent exposure (28). 
6.3 Corrosives 
Chemical burns are caused by a number of exposures: extreme pH (acids and 
bases), reactive chemicals e.g. oxidising or reducing, phenols, some organic 
solvents, and some concentrated preservatives.  
The destruction of tissue leading to chemical burn can likely be attributed to the 
various chemical reactions caused by the irritants. Chemical burn related to pH is 
either from low acidic pH (< 4) or from high alkaline pH (> 10). Skin exposure to 
extreme pH usually disrupts the natural buffer balance in the tissue. Acids denature 
protein and thus affect its absorption and lead to formation of blisters and dermal 
necrosis. High pH is associated with saponification of triglycerides and dissolution 
of proteins in the skin. This is seldom associated with acute pain and the acute 
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exposure may therefore be overlooked, resulting in prolonged exposure and severe 
reactions in the skin. It is not just the obvious exposures to strong alkali that can 
give chemical burns but also several alkaline compounds such as amines (31). 
Hydrofluoric acid (HF), apart from being strongly corrosive, is also a strong 
binder of Ca2+ ions. Exposure to HF leads to acidic destruction of the skin and 
may also have systemic effects by generating hypocalcaemia. Reactive chemicals 
oxidise or reduce the tissues in the skin and give rise to chemical burn. One 
example of a strong oxidising agent is hypochlorite that is present in chlorine 
bleaches. Phenols are easily absorbed through the skin and give rise to local 
effects on the nerves and blood vessels leading to necrosis and chemical burn. 
Sulphuric acid causes chemical burn and may also cause thermal burn, as heat is 
generated when strong sulphuric acid is exposed to water. The risk of acquiring  
a chemical burn is usually diminished at lower concentration (31). 
7. Methods to assess skin exposure and skin effects 
7.1 Skin exposure assessment  
Traditionally, occupational hygiene has focused on assessment of airborne 
exposure, but during the last decade several methods to measure skin exposure 
have been developed and to some extent standardised. Methods for sampling from 
the skin surface are most common since they are less invasive, but methods for 
sampling the skin, assessing uptake into and through skin and for biomonitoring 
also exist.  
7.1.1 Estimation of skin surface dose 
Estimating the dose of a chemical on the skin surface (µg/cm2) is of importance 
when discussing contact allergy, since the dose is the determinant of development 
or onset of the allergy. Several methods exist to measure the presence and the 
dose of a chemical on skin. Three major measurement strategies have been 
identified (67):  
- Removal techniques 
- Surrogate skin techniques (interception techniques) 
- Fluorescent tracer techniques 
These three main techniques have been used frequently to monitor both 
occupational and consumer skin contamination by different groups of chemicals 
and contact allergens.  
7.1.1.1 Removal techniques 
All removal techniques actually remove substances from the skin. The most 
commonly used technique involves moistened wipes. Wipe sampling of elements 
from surfaces has been described by US NIOSH (155). In this method, pre-
packaged moist disposable wipes are rubbed on each surface in an overlapping  
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S-pattern. The wipes are then digested using concentrated nitric acid (HNO3) and 
perchloric acid (HClO4), before dilution and analysis of metals using ICP-AES.  
A drawback with the method is that the wipe-moisturising solvent is undefined.  
Later, a standardised technique called acid wipe sampling (135) was developed 
to analyse the dose of nickel, cobalt and chromium on the skin. In short, a cellu-
lose wipe moistened with 0.5 ml of 1% HNO3 is used to wipe the skin. Three 
consecutive wipes are used to sample from one area. The wipes are pooled and 
extracted in 1% HNO3 for 30 minutes. The extract is then analysed chemically 
using graphite furnace-atomic absorption spectrometry (GF-AAS) or ICP-MS. 
The recovery is > 90% and most of the metals are removed with the first wipe. 
The major difference between the two methods is that the solvent for wiping is 
clearly defined in acid wipe sampling. This reduces the variability in sampling 
efficiency and the risk of exposing the skin to harmful substances (such as 
preservatives and fragrance substances) during sampling. Acid wipe sampling  
has been used to measure metal content on the skin in several occupations (113, 
136), and in manipulation experiments with tools (114) and coins (112, 137) in  
the laboratory.  
Another strategy to measure metals on skin is the finger immersion method 
(198), in which fingers are immersed in tubes containing Milli-Q water for 2 
minutes with gentle agitation. After removing the finger from the tube, the solution 
is acidified using HNO3. The technique requires a sensitive chemical analysis 
such as ICP-MS to determine the metal content in the water. A drawback is the 
difficulty of calculating the exact dose per skin surface area, since the entire finger 
is dipped into the water. The method has been used to evaluate exposure to nickel 
in different occupations (79).  
Hand washing and hand rinsing techniques have also been developed. A 
washing technique involves mechanical agitation like rubbing the hands together, 
whereas rinsing mainly involves a wet chemical dissolution (30). Both methods 
have been used extensively to monitor occupational exposure to pesticides and are 
standard procedures in the US for sampling of several pesticides (216). Usually 
one hand is washed or rinsed with a solvent like isopropanol or water (68, 91) and 
the liquid is then analysed chemically using high performance-liquid chromato-
graphy (HPLC) often in combination with MS. Hand wash sampling with bag 
rinsing was also used in a study of permanent hair dyes (139). The solvent in this 
case was a buffer solution in combination with ethanol. The sampling efficiency 
(i.e. recovery) was between 70 and 90% for the different compounds studied. 
One major issue to consider when designing a study using washing, rinsing or 
wiping techniques is which material to use. The type of wipe, solvent, soap or bag 
may influence both the absorption of sample from skin and the chemical analysis. 
An ideal sampling technique should not be harmful to the skin (not containing 
allergens or irritants) and should have a high sampling efficiency.  
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Figure 7. Tape stripping of skin (photo by Julander A). 
To collect particles from the skin, a method using a small vacuuming sampler 
was developed (143). Using a standard air pump connected by tubing to a filter 
cassette, particles deposited on the skin can be removed by suction and collected 
on the filter. The filter can then be analysed chemically or put into a microscope  
for visual identification of particle morphology or composition. Such a suction 
sampler is ideal for sampling of large skin areas.  
Another method to remove particles from the skin is tape stripping (92). An 
area of the skin can repeatedly be stripped off using a piece of tape (Figure 7). The 
number of times that the area is stripped depends on the purpose of the study. To 
collect particles from the skin surface, no more than 3 strips are required and it 
can be done to monitor exposure at workplaces. The tape strips are treated in the 
same way as the filter mentioned above, i.e. chemical dissolution and analysis or 
using a microscopic technique to visualise the particles. 
7.1.1.2 Surrogate skin 
When the skin surface itself cannot be sampled, patches, whole-body coveralls  
or gloves may be used (91). Patches can be put onto the clothes, under protective 
clothes or onto the naked skin to assess potential or actual skin exposure. The 
method is commonly used, especially for occupational studies investigating 
pesticide exposure of agricultural workers (69), but it has also been used for 
analysing metalworking fluids and electroplating fluids (175). The material used 
for patches may be cotton or other types of fabrics, filter paper or other materials. 
The patches are applied before the work starts and removed at end of shift, the 
substance is extracted and chemically analysed. Using this technique, large areas 
of the body can be scanned for contamination; however, the measure is always 
only an estimate of the true skin dose. 
7.1.1.3 Fluorescence technique 
If determining the skin exposure dose is not the objective of the study, but rather 
to find out which areas of the skin or the work environment that are contaminated, 
a fluorescent tracer can be used for qualitative or semi-quantitative assessment. 
Commonly used tracers are laundry whiteners that do not harm the skin. In brief, 
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the fluorescent tracer is mixed with the formulation of interest prior to use. 
After performing the work under assessment, exposure can be visualised from  
the fluorescence by using UV-light in a semi-dark room. The technique has  
been used to determine exposure to pesticides (11) and dental acrylates (179). 
7.1.1.4 Dimethylglyoxime test 
Apart from the three major techniques discussed thus far, the dimethylglyoxime 
(DMG) test (Section 5.1.1) is applicable to screen for the presence of nickel on  
the skin surface. In the DMG test (also called the nickel test), a cotton-wool stick 
with a drop of test solution on the tip is rubbed against the skin or an item for  
30 seconds, and will yield a pink colour if nickel ions are present on the surface 
(114). The test can be used in a semi-quantitative manner to perform a quick scan 
of working environments. It is important not to use the test on damaged skin, or 
skin with eczema or fissures.  
7.1.2 Biomonitoring of exposure 
Classical biomonitoring of exposure uses blood or urine samples (sometimes even 
hair and nail clippings) to determine uptake of a substance which is of importance 
for chemicals that pass the skin and thereby cause systemic effects (Chapters 4 
and 9). However, these techniques are not suitable for monitoring of local effects 
in the skin.  
To measure the amount of a chemical present in the skin, two standard derma-
tological methods are available: tape stripping and skin punch biopsies. Both 
techniques are also used by clinicians when investigating patients for purposes 
other than measuring uptake into the skin, e.g. to diagnose skin disorders. The 
tape stripping method, described in the previous section, can be expanded by 
taking more strips from the same area. If uptake in skin is to be evaluated, at least 
10 tapes are needed from the same area. The method has been used to evaluate 
penetration of nickel salts and copper into the skin (92, 93). To trace the con-
taminants down through the skin layers, 20 tape strips were taken from the same 
area, until the glistening epidermal layer was exposed. The technique is reliable 
but rather invasive and will give rise to a wound in the skin. Therefore, it should 
be used with caution and not as a tool for assessing exposure in the workplace. 
For workplace assessments, no more than 3–5 tapes should be used to prevent 
damage to the skin and allow the worker to continue work after sampling.  
Taking skin punch biopsies is also invasive and requires local anaesthesia. 
Using biopsies, different layers of the skin can be evaluated for chemical 
penetration and transport in the skin. One example of using biopsies is tracing  
of nanoparticles in the skin after application of sun screens (153). The biopsy can 
be evaluated using various microscopic techniques, either in its entirety or after 
slicing into thin section.  
7.1.3 Examples of occupational skin exposure data 
Table 3 displays a non-exhaustive list of data concerning exposure of skin on 
hands, obtained by different methods. 
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Table 3. Examples of skin exposure of hands in different occupations. Sampling by 
different techniques (rounded values). 
Occupation 
(n = x) 
Sampling  
method 
Substance Skin surface dose 
(µg/cm2/h),  
arithmetic mean if not 
stated otherwise a 
Reference 
Locksmiths 
(n = 3) 
Acid wipe  Ni 
Co 
Cr 
0.36 
0.002 
0.045 
(136) 
Cashiers 
(n = 7) 
Acid wipe  Ni 
Co 
Cr 
0.20 
0.002 
0.003 
(136) 
Office staff 
(n = 4) 
Acid wipe  Ni 
Co 
Cr 
0.018 
0.001 
0.002 
(136) 
Carpenters 
(n = 4) 
Acid wipe  Ni 
Co 
Cr 
0.077 
0.002 
0.007 
(136) 
Metal workers  
(tool sharpening) 
(n = 8) 
Acid wipe  Ni 
Co 
Cr 
0.068 
0.36 
0.011 
(113) 
Metal workers 
(components) 
(n = 8) 
Acid wipe Ni 
Co 
Cr 
0.52 
0.050 
0.056 
(113) 
Metal workers 
(thermal applications) 
(n = 8) 
Acid wipe Ni 
Co 
Cr 
0.41 
0.14 
0.014 
(113) 
Electroplaters 
(n = 5) 
Finger immersion 
(water) 
Ni 1.8 b (79) 
Cashiers 
(n = 7) 
Finger immersion 
(water) 
Ni 0.15 b (79) 
Sales assistants 
(n = 5) 
Finger immersion 
(water) 
Ni 0.10 b (79) 
Office staff 
(n = 5) 
Finger immersion 
(water) 
Ni 0.062 b (79) 
Furniture industry 
workers 
(n = 36) 
Tape stripping TPGDA 0.38 
30 µg/10 cm2/work shift c 
(202) 
Hairdressers 
(n = 33) 
Hand rinsing 
(plastic bag, 
buffer solution) 
PPD   22–940 nmol/hand d (138) 
Metal workers 
(n = 37) 
Hand rinsing 
(plastic bag, 
isopropanol) 
EA 
DEA 
EA+TEA 
10  e 
19  e 
1.9+3.4 e 
(90) 
a Sampling areas differed between studies, see original publications for details. 
b Sampling after at least 1 hour of normal work; correction factor for surface area applied. 
c 8-hour work shift according to Jouni Surakka (personal communication).  
d Sampling after hair dye application, cutting newly-dyed hair (min-max). 
e Sampling after 2 hours work with metalwork fluids, median value mg/dominant hand. 
DEA: diethanolamine, EA: monoethanolamine, PPD: p-phenylenediamine, TEA: triethanolamine, 
TPGDA: tripropylene glycol diacrylate. 
 30 
7.2 Methods to assess skin sensitising potential and potency 
7.2.1 Experimental sensitisation in humans  
Experimental testing of a chemical’s inherent ability to sensitise may be 
performed according to a variety of methods. Predictive tests such as the human 
repeated insult patch test (HRIPT) and human maximisation test (HMT) are 
performed in healthy volunteers to study induction of sensitisation. Such studies 
may be of historical relevance but new studies are prohibited by EU regulations 
(50, 63, 186). This type of testing is now considered unethical, as participants  
may develop lifelong contact allergy by the experiment. HRIPT studies are still 
performed on behalf of industry, often outside Europe (183). 
7.2.2 Experimental sensitisation in animals 
Another approach, which is fairly relevant to skin sensitisation in humans, is to 
perform sensitisation/elicitation studies on experimental animals. The animal of 
choice is often the guinea pig, e.g. in the guinea pig maximisation test (GPMT) 
and Buehler test.  
Since the mid-1980s, an alternative method to study the induction phase in  
mice has been developed: the local lymph node assay (LLNA). This method is 
relatively fast and cheap (14). The LLNA has an inherent dose-response design 
and can be used to assess sensitising potency, which is useful for classification 
and subcategorisation of skin sensitisers (Table 4) (15). This can also be done 
with the GPMT, by a method alteration. The LLNA has a few drawbacks, such  
as studying only the induction phase and not elicitation, not being able to detect 
cross-reactivity to chemicals, and being sensitive to irritants that may give false 
positives. The results from LLNA are also dependent on the vehicle used. LLNA 
is better at inducing sensitisation to organic chemicals than to metals. It is difficult 
to sensitise mice to nickel, as the receptor responsible for binding metals and 
starting the immunological response is different from that in humans (188).  
The above methods shall be used, and the LLNA is currently the first choice 
method, for regulatory purposes for hazard identification by assessing sensitising 
potential and potency (63, 65). The OECD has developed guidelines for the 
methods (see Appendix 1). A compilation of LLNA results and EC3 values1 for 
204 substances (fragrance substances, preservatives and hair dye substances), 
conditions for their use according to the Cosmetics Regulation (64) and harmonised 
classification as skin sensitiser (H317)2 according to the CLP Regulation (63) has 
been published (128).  
The European Chemicals Agency (ECHA) has published guidelines for the 
requirements for risk characterisation and derivation of derived no-effect levels 
(DNELs) for skin sensitisation, and for classification and labelling based on 
animal data (Table 4) (49, 50) (Section 7.2.3). 
                                                 
1 Estimated concentration to cause a 3-fold increase in draining lymph-node cell proliferative 
activity. 
2 May cause an allergic skin reaction. 
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Table 4. Skin sensitising potency based on LLNA EC3 values. Classification as  
skin sensitiser (H317) subcategories and recommended concentration limits for 
classification of mixtures according to the CLP Guidance 2017 (50). 
EC3 value Potency  H317 subcategory Concentration limit for 
classification of mixtures 
≤ 0.2% Extreme 1A 0.001% 
> 0.2% to ≤ 2% Strong 1A 0.1% 
> 2%  Moderate 1B 1% 
CLP: classification, labelling and packaging of substances and mixtures, EC3: estimated 
concentration to cause a 3-fold increase in draining lymph-node cell proliferative activity,  
H317: may cause an allergic skin reaction, LLNA: local lymph node assay.  
7.2.3 Non-animal based models 
Current assessment of skin sensitisation relies mainly on animal tests; however, a 
ban on animal testing of chemicals to be used in cosmetic products was introduced 
in the European Cosmetic Products Enforcement Regulations 2013 (64). This, and 
also the REACH legislation, have stressed the urgent need for in vitro and in silico 
methods for the prediction of the sensitising potential and sensitising potency of 
chemicals. The REACH Guidance on information requirements in Annex VII in 
relation to skin sensitisation has been updated, taking into account how to predict 
the sensitising potential based on non-animal methods (49). Two in vitro methods 
for prediction of skin sensitising potential and one in chemico test have until now 
been validated and accepted as OECD test guidelines (Appendix 1). 
In silico methods in the field of skin sensitisation are mainly based on models 
of (quantitative) structure-activity relationships or (Q)SARs and expert systems 
with knowledge-based information on relevant toxicological endpoints. In vitro 
methods include in chemico tests that investigate the ability of a specific chemical 
to react with selected peptides, so as to predict the sensitisation potential, and 
cellular tests. Currently available in silico and in vitro methods to predict 
sensitisation in humans, and methods under development, were discussed and 
summarised in a recent review (207). The review concluded that a number of  
in silico and in vitro methods may potentially become useful for the prediction  
of the sensitising potential of chemicals in a regulatory context.  
Current general drawbacks are that the methods cannot yet predict sensitising 
potency [required in the CLP Regulation and for subcategorisation into 1A (strong 
or extreme) and 1B (moderate)], and are poor at predicting which chemicals are 
non-sensitisers, pre-haptens (sensitisers formed by oxidation), prohaptens 
(sensitisers formed by metabolic activation) or cause cross reactivity.  
7.2.4 Diagnostic patch testing and use tests in humans 
Diagnostic patch testing is the procedure used to diagnose contact allergy (99). 
Patch testing is performed in patients with dermatitis and in experimental and 
epidemiological studies. The test procedure is standardised. The European 
baseline series for routine patch testing consists of 30 compounds (in total 59 
different substances) in validated concentrations and vehicles. Patch testing  
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is performed also with additional substances, test series, mixtures and solid 
materials in specialised clinics. The test material is applied to the upper back  
and removed after 2 days. Reading on two occasions is recommended; general 
practice in Sweden is to read 3 days and 5–7 days after application. Evaluation  
of test reactions is performed according to internationally agreed criteria (99). 
Other clinical test methods simulating normal exposure are sometimes used  
for elicitation in individuals with contact allergy. Examples are the repeated open 
application test (ROAT), shampoo use test, axillary test and finger immersion  
test. These methods use commercial products (mixtures) and substances at use 
concentrations or other defined concentrations. They may be performed in the 
clinic to verify a patient’s allergy to products and in dose-response studies for 
research and risk assessment (73, 99, 234). 
7.2.5 Dose-response studies in humans 
Both induction and elicitation of contact allergy display dose-response relation-
ships and have thresholds. The threshold for induction can be defined as the 
highest level of exposure that fails to induce sensitisation. The threshold for 
elicitation can be defined as the highest level of exposure that fails to elicit a 
reaction in a previously sensitised subject. Thresholds for induction in humans  
are difficult to set while thresholds for elicitation can be set by dose-response 
testing in previously sensitised individuals, often dermatitis patients (15, 46).  
The minimum elicitation dose that gives a reaction in 10% of sensitised subjects 
(ED10) has been set for some skin sensitising metals, fragrance substances and 
preservatives, and is useful in risk assessment. Examples are displayed in Figure 8 
and Table 5. The results in Table 5 show that the EC3 values (induction by LLNA 
in mice) (Section 7.2.2) and ED10 values (elicitation by patch test in sensitised 
individuals) for the same substance may differ by several orders of magnitude, 
illustrated by the broad span in the quotient between EC3 and ED10 values. This 
is important to consider, since it has sometimes been suggested that regulatory 
measures such as specific concentration limits for classification, information or 
restrictions could be based on EC3 values. It has also been shown that there is 
good correspondence between dose-response testing by patch test and by ROAT 
(72, 73). 
It was concluded in the SCCS opinion on fragrance allergens that elicitation 
data in humans can provide thresholds indicative for safe use of substances which 
have already caused significant clinical problems. In the absence of adequate 
substance-specific data, however, it is possible to use a general threshold. A 
threshold of 0.8 μg/cm2, corresponding to 0.01% in cosmetic products, was 
suggested based on statistical analysis of the available data (184). 
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Figure 8. Dose-response curves for 8 skin sensitisers (fragrance substances, metals  
and preservatives) determined by patch testing of allergic individuals. The intersection 
between the horizontal line and a dose-response curve indicates the ED10 value (i.e.  
the minimum dose that will elicit a positive response in 10% of sensitised individuals). 
Based on data from Fischer et al. 2011 (72). 
Table 5. EC3 values in the LLNA compared with doses that elicit positive response  
by patch test in 10% of allergic individuals (ED10) with the same substances. Based  
on data from 16 studies reviewed by Fischer et al. 2011 (72). 
Substance    EC3 (µg/cm2) a   ED10 (µg/cm2) b    EC3/ED10 c 
CMIT/MIT 1.225 1.05 1.2 
Formaldehyde 135 20.1 6.7 
Nickel 140 1.58; 0.82; 7.49; 
0.74; 0.82 
141.4 d 
Cobalt 297 0.44 675 
Chromium 10 1.04 9.6 
Isoeugenol 550 1.48; 0.23  640 
HICC 4 275 0.85; 1.17; 0.66  4 803 
MDBGN 325 0.025; 0.5  1 250 
a EC3 values are normally given as %, however here as µg/cm2 for comparison with ED10. 
b The ED10 values in italic are from the 8 studies shown in Figure 8.  
c The mean ED10 value was used when more than one ED10 value was available. 
d Outlier excluded. 
CMIT/MIT: methylchloroisothiazolinone/methylisothiazolinone (3:1), EC3: estimated 
concentration to cause a 3-fold increase in draining lymph-node cell proliferative activity,  
ED10: minimum elicitation dose giving a reaction in 10% of sensitised subjects,  
HICC: hydroxyisohexyl 3-cyclohexene carboxaldehyde, LLNA: local lymph node assay, 
MDBGN: methyldibromo glutaronitrile. 
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7.2.6 Dose-response studies in animals 
Dose-response relationships for chemicals with inherent ability to induce contact 
allergy can fairly easily be studied in predictive testing. The GPMT can be modi-
fied to study dose-response both in sensitisation and elicitation (6). The LLNA  
has in itself a dose-response design at induction, but does not study the eliciting 
phase (119). A modified LLNA employing both induction and elicitation has been 
introduced; a method useful for dose-response and cross-reactivity studies (125). 
Different vehicles may influence the result significantly, as shown in Figure 9, 
which may result in different classification and subcategorisation (1A or 1B) as 
skin sensitiser (Table 4).  
7.3 Methods for evaluation of skin irritation and corrosion 
Several methods are described in OECD standards for testing skin irritation and 
skin corrosion. Some methods use rabbits or rats as test animals, others use human 
or reconstructed human skin. For a full reference of guidelines and test methods 
(both in vivo and in vitro), see Appendix 1.  
There is no clinical test method to prove that contact dermatitis is caused by skin 
irritancy (77). The diagnosis of irritant contact dermatitis is based on the result of 
exposure assessment and the exclusion of contact allergy by patch testing. 
8. Previous evaluations by national and international bodies 
The World Health Organization (WHO) published an Environmental Health 
Criteria (EHC) monograph on dermal exposure in 2014 (228), which concluded 
that dermal exposure to chemicals and products is an important exposure route 
and that resulting diseases may have significant impact on human health. The 
monograph also concluded that the best risk management approach is to identify 
hazards, sources and pathways for risk assessment, and to eliminate or reduce  
and control the exposure.  
EU-OSHA published a report from the European Risk Observatory on occupa-
tional skin diseases and dermal exposure in 2008 (53) and another on priorities for 
occupational safety and health research in 2013 (54). It was concluded that skin 
diseases are the second most common work-related health problem in Europe and 
one of the most important emerging risks related to chemical risk factors. The 
importance of recognising risk factors and developing methods for assessing and 
controlling the exposure was emphasised.  
In 2010, US OSHA likewise stressed that skin exposure to chemicals in the 
workplace is a significant problem and stated that recordable skin disease in the 
US exceeds recordable respiratory illnesses. It is concluded that most chemicals 
are readily absorbed through the skin, which in many cases is a more significant 
route of exposure than inhalation (217). According to the US Bureau of Labor 
Statistics report from 2015, the number of occupational illnesses caused by skin 
absorption of chemicals in the US is unknown (26). 
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Figure 9. Preservatives tested by the LLNA in mice in the same experiment. Two 
vehicles (acetone/olive oil; propylene glycol) were used for comparison of induction 
potency. If the EC3 is reached, the substance fulfils the criteria for classification as 
skin sensitiser. Based on data from Basketter et al. 2003 (17).  
CMIT/MIT: methyl-chloroisothiazolinone/methylisothiazolinone (3:1),  
EC3: estimated concentration to cause a 3-fold increase in draining lymph-node cell 
proliferative activity, LLNA: local lymph node assay. 
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9. Current regulations, standards and guidelines  
9.1 Skin notations for the work environment 
The “skin notation” is a warning that a substance may easily be absorbed via  
the skin. It is usually communicated as “S”, “Sk” or “Skin” (in English) in 
conjunction with the OEL value for the substance. Skin notations are used by 
many organisations and in many countries. The criteria for assigning a skin 
notation vary widely but most are qualitative rather than quantitative in nature 
(Table 6). During the last decades, focus has shifted towards more quantitative 
assessments, basically moving from level 1 to 3 in the following scheme (107): 
Skin notation assigned based on: 
1. the intrinsic properties of the chemical in numerical terms, such as dermal 
absorption rate in defined conditions. 
2. the dermally absorbed dose, i.e. a combination of intrinsic properties and 
defined exposure conditions (exposed skin area, exposure duration, etc.). 
3. the dermally absorbed dose relative to the inhaled dose in defined 
conditions. 
Gorman et al. (84) recently presented a tool (UPERCUT) for assigning skin 
notation corresponding to the third level in the scheme above. The tool uses 
quantitative dermal absorption data and QSAR estimates to calculate the systemic 
dose via skin and OEL values (or toxicological data in the absence of an OEL) to 
calculate the acceptable dose. 
For substances with significant dermal absorption, biological exposure moni-
toring may be preferable to air monitoring, as the former captures all routes of 
exposure including skin. The EU Scientific Committee on Occupational Exposure 
Limits (SCOEL) has decided to recommend biological limit values (in addition to 
OELs) (Section 10.1) for compounds with a skin notation as a priority (193). 
The skin notation has several shortcomings. The first major problem is that 
common criteria do not exist and that the variable criteria (Table 6) and missing, 
unreliable or contradictory dermal absorption data (43, 107) (see Chapter 4  
for more details) result in divergent classifications by different countries and 
organisations (107, 154, 180, 205). Second, skin notations are assigned rather 
generously. Thus, approximately one third of the chemicals with an OEL have a 
skin notation (107, 154). This may undermine the warning effect of the notation. 
Third, the categorical (yes/no) nature of the skin notation may mask the enormous 
differences in skin permeability between substances (107). Fourth, none of the 
criteria explicitly account for the huge differences in evaporation of chemical 
from the skin. This is an important aspect, as evaporation reduces the amount  
of chemical available for dermal absorption. The evaporation rate differs by 
several orders of magnitude between chemicals with a skin notation (105, 106).  
Johanson et al. compared evaporation and dermal absorption rates by com-
bining experimental data and theoretical calculations for 54 chemicals with a skin 
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notation. Under the assumption of identical exposure conditions (exposed skin 
area, film thickness, wind speed), the investigated chemicals varied by 8 orders  
of magnitude in evaporation rate, by 5 orders of magnitude in absorption rate, 
from 2% to 100% in dermally absorbed dose, and by 6 orders of magnitude in 
time required to reach a toxic systemic dose. The investigators concluded that 
evaporation needs to be taken into account when setting skin notations (105).  
The issue of occluded exposure, e.g. inside clothing or protective gloves, was  
not addressed at this point. 
It was further noted that more than one third of the chemicals that fulfilled  
the ECETOC criteria (Table 6) for a skin notation lacked such a notation in the 
Swedish OEL regulation (12). The authors therefore suggested that all substances 
in the Swedish OEL list should be revised with respect to skin notations.  
9.2 Notations for sensitisers 
Many OEL setters (e.g. US NIOSH, see Table 6) use a single notation to warn for 
sensitising substances and thus do not differentiate between respiratory and skin 
sensitisers. The EU SCOEL acknowledges that although some sensitisers may 
affect both the respiratory system and the skin, different mechanisms are involved 
and the majority of skin sensitisers do not affect the respiratory system. SCOEL 
uses notations for respiratory (193) and dermal sensitisers (Table 6). Also some 
other organisations, e.g. the American Conference of Governmental Industrial 
Hygienists (ACGIH) and Deutsche Forschungsgemeinschaft (DFG) differentiate 
between respiratory and skin sensitisers in their notations (Table 6).  
9.3 Restrictions for prevention of skin sensitisation  
Skin sensitisation (contact allergy and allergic contact dermatitis) is addressed in 
the EU legislations on chemicals and cosmetics. Measures intended to prevent 
skin sensitisation – induction as well as elicitation – have been applied. They 
include classification and warning labelling, ingredient labelling, and restriction  
of use. All chemicals regulations state that available human data showing skin 
sensitisation shall be used, and give reference to the CLP Regulation (63) con-
cerning how classification shall be done. A brief overview is given in Table 7.  
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ti
v
it
y
 
p
ro
b
le
m
s 
m
ai
n
ly
 a
ff
ec
t 
th
e 
sk
in
 o
r 
re
sp
ir
at
o
ry
 o
rg
an
s.
 
(1
2
) 
N
IO
S
H
, 
U
S
 
S
K
: 
S
Y
S
 
S
K
: 
S
Y
S
(F
A
T
A
L
) 
S
K
: 
D
IR
 
 S
K
: 
D
IR
(I
R
R
) 
S
K
: 
D
IR
(C
O
R
) 
S
K
: 
S
E
N
 
P
o
te
n
ti
al
 t
o
 c
o
n
tr
ib
u
te
 s
u
b
st
a
n
ti
al
ly
 t
o
 s
y
st
e
m
ic
 t
o
x
ic
it
y
 t
h
ro
u
g
h
 d
er
m
al
 a
b
so
rp
ti
o
n
. 
H
ig
h
ly
 o
r 
ex
tr
e
m
el
y
 t
o
x
ic
 a
n
d
 p
o
te
n
ti
al
ly
 l
et
h
al
 o
r 
li
fe
-t
h
re
at
en
in
g
 f
o
ll
o
w
in
g
 a
c
u
te
 c
o
n
ta
ct
 w
it
h
 t
h
e 
sk
in
. 
In
d
ic
at
es
 n
o
n
-i
m
m
u
n
e 
m
ed
ia
te
d
 d
ir
ec
t 
ef
fe
ct
(s
) 
o
f 
a 
ch
e
m
ic
al
 o
n
 t
h
e 
sk
in
 a
t 
o
r 
n
ea
r 
th
e 
p
o
in
t 
o
f 
co
n
ta
ct
, 
in
cl
u
d
in
g
 
co
rr
o
si
o
n
, 
p
ri
m
ar
y
 i
rr
it
at
io
n
, 
b
le
ac
h
in
g
 (
b
la
n
c
h
in
g
),
 s
ta
in
in
g
, 
an
d
 r
ed
u
ct
io
n
/d
is
ru
p
ti
o
n
 o
f 
th
e 
sk
in
 b
ar
ri
er
 i
n
te
g
ri
ty
. 
 
A
 s
u
b
n
o
ta
ti
o
n
 o
f 
D
IR
, 
in
d
ic
at
es
 t
h
at
 a
 c
h
e
m
ic
al
 i
s 
a 
sk
in
 i
rr
it
an
t.
 
A
 s
u
b
n
o
ta
ti
o
n
 o
f 
D
IR
, 
in
d
ic
at
es
 t
h
at
 a
 c
h
e
m
ic
al
 i
s 
a 
co
rr
o
si
v
e.
 
In
d
ic
at
es
 t
h
a
t 
sk
in
 e
x
p
o
su
re
 t
o
 a
 c
h
e
m
ic
al
 m
a
y
 c
au
se
 o
r 
co
n
tr
ib
u
te
 t
o
 t
h
e 
o
n
se
t 
o
f 
al
le
rg
ic
 c
o
n
ta
ct
 d
er
m
at
it
is
 o
r 
o
th
er
 
im
m
u
n
e
-m
ed
ia
te
d
 r
es
p
o
n
se
s,
 s
u
c
h
 a
s 
ai
rw
a
y
 h
y
p
er
re
ac
ti
v
it
y
 (
as
th
m
a)
. 
(1
5
6
) 
a 
S
C
O
E
L
 h
as
 r
ec
e
n
tl
y
 i
n
tr
o
d
u
c
ed
 a
 n
o
ta
ti
o
n
 f
o
r 
d
er
m
al
 s
e
n
si
ti
sa
ti
o
n
 a
n
d
 i
s 
cu
rr
en
tl
y
 u
p
d
at
in
g
 t
h
ei
r 
m
et
h
o
d
o
lo
g
y
 d
o
cu
m
e
n
t 
(1
9
3
).
 
A
C
G
IH
: 
A
m
er
ic
an
 C
o
n
fe
re
n
c
e 
o
f 
G
o
v
er
n
m
e
n
ta
l 
In
d
u
st
ri
al
 H
y
g
ie
n
is
ts
, 
D
F
G
: 
D
e
u
ts
c
h
e 
F
o
rs
ch
u
n
g
sg
e
m
e
in
sc
h
a
ft
 (
G
er
m
an
 R
e
se
ar
ch
 F
o
u
n
d
at
io
n
),
 E
C
E
T
O
C
: 
E
u
ro
p
ea
n
 
C
en
tr
e 
fo
r 
E
co
to
x
ic
o
lo
g
y
 a
n
d
 T
o
x
ic
o
lo
g
y
 o
f 
C
h
e
m
ic
al
s,
 E
U
: 
E
u
ro
p
ea
n
 U
n
io
n
, 
N
IO
S
H
: 
N
a
ti
o
n
al
 I
n
st
it
u
te
 f
o
r 
O
cc
u
p
at
io
n
al
 S
af
et
y
 a
n
d
 H
ea
lt
h
, 
O
E
L
: 
o
cc
u
p
at
io
n
al
 
ex
p
o
su
re
 l
im
it
, 
S
C
O
E
L
: 
S
ci
e
n
ti
fi
c 
C
o
m
m
it
te
e 
o
n
 O
cc
u
p
at
io
n
al
 E
x
p
o
su
re
 L
im
it
s,
 S
T
M
: 
M
in
is
tr
y
 o
f 
S
o
ci
al
 A
ff
ai
rs
 a
n
d
 H
ea
lt
h
, 
S
W
E
A
: 
S
w
ed
is
h
 W
o
rk
 E
n
v
ir
o
n
m
e
n
t 
A
u
th
o
ri
ty
, 
T
W
A
: 
ti
m
e-
w
ei
g
h
te
d
 a
v
er
ag
e,
 U
S
: 
U
n
it
ed
 S
ta
te
s.
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E
x
am
p
le
s 
o
f 
E
U
 r
eg
u
la
ti
o
n
s 
w
it
h
 m
ea
su
re
s 
ai
m
in
g
 a
t 
th
e 
p
re
v
en
ti
o
n
 o
f 
sk
in
 s
en
si
ti
sa
ti
o
n
. 
R
eg
u
la
ti
o
n
 
(r
ef
er
en
ce
) 
M
ea
su
re
 
S
u
b
st
a
n
ce
, 
li
m
it
 v
al
u
e 
o
r 
ap
p
li
ca
ti
o
n
 
S
h
o
rt
co
m
in
g
s 
in
 r
el
at
io
n
 t
o
 p
re
v
en
ti
o
n
. 
A
sp
ec
ts
 
d
is
cu
ss
ed
 i
n
 r
ef
er
e
n
ce
s 
(7
2
, 
1
9
1
, 
1
9
2
, 
2
1
4
, 
2
2
0
) 
C
L
P
  
(5
0
, 
6
3
) 
C
la
ss
if
ic
at
io
n
 a
s 
sk
in
 
se
n
si
ti
se
r 
(H
3
1
7
) 
b
y
 
h
ar
m
o
n
is
ed
 c
la
ss
if
ic
at
io
n
 
(l
eg
al
ly
 b
in
d
in
g
) 
o
r 
n
o
ti
fi
ed
 (
b
y
 i
n
d
u
st
ry
).
 
G
en
er
at
es
 w
ar
n
in
g
 
la
b
el
li
n
g
 a
n
d
 i
n
fo
rm
a
ti
o
n
 
o
n
 p
ac
k
ag
e
s 
ab
o
v
e 
 
ce
rt
ai
n
 c
o
n
ce
n
tr
at
io
n
s 
 
in
 p
ro
d
u
ct
s.
 
G
en
er
ic
 c
o
n
ce
n
tr
at
io
n
 l
im
it
s 
fo
r 
cl
as
si
fi
ca
ti
o
n
 o
f 
m
ix
tu
re
s 
ar
e 
1
%
 f
o
r 
ca
te
g
o
ry
 1
 a
n
d
 s
u
b
ca
te
g
o
ry
 1
B
 (
m
o
d
er
at
e 
se
n
si
ti
se
rs
),
 
an
d
 0
.1
%
 f
o
r 
su
b
ca
te
g
o
ry
 1
A
 (
st
ro
n
g
) 
an
d
 r
ec
o
m
m
e
n
d
ed
 
0
.0
0
1
%
 f
o
r 
su
b
ca
te
g
o
ry
 1
A
 (
e
x
tr
e
m
e)
. 
S
p
ec
if
ic
 c
o
n
ce
n
tr
at
io
n
 l
im
it
s 
c
an
 b
e 
se
t 
fo
r 
th
e 
m
o
st
 p
o
te
n
t 
se
n
si
ti
se
rs
. 
In
fo
rm
a
ti
o
n
 o
n
 p
ac
k
a
g
e 
ab
o
u
t 
co
n
te
n
t 
o
f 
cl
as
si
fi
ed
 s
e
n
si
ti
se
r 
ab
o
v
e 
ce
rt
ai
n
 c
o
n
ce
n
tr
at
io
n
s,
 i
n
te
n
d
ed
 t
o
 p
ro
te
ct
 a
lr
ea
d
y
 
se
n
si
ti
se
d
: 
C
h
ro
m
iu
m
 (
V
I)
 (
E
U
H
2
0
3
),
 i
so
cy
an
a
te
s 
(E
U
H
2
0
4
);
 
an
d
 e
p
o
x
y
 (
E
U
H
2
0
5
) 
re
g
ar
d
le
ss
 o
f 
co
n
ce
n
tr
at
io
n
s;
 a
n
d
 o
f 
al
l 
cl
as
si
fi
ed
 s
k
in
 s
en
si
ti
se
rs
 (
E
U
H
2
0
8
) 
in
 m
ix
tu
re
s:
 ‘
C
o
n
ta
in
s 
(t
h
e 
n
am
e)
. 
M
ay
 p
ro
d
u
ce
 a
n
 a
ll
er
g
ic
 r
ea
ct
io
n
.’
 
T
h
e 
co
n
ce
n
tr
at
io
n
 l
im
it
s 
fo
r 
cl
as
si
fi
ca
ti
o
n
 a
re
 g
en
er
al
ly
 
fa
r 
to
o
 h
ig
h
 f
o
r 
p
re
v
en
ti
o
n
 o
f 
in
d
u
ct
io
n
 a
n
d
 e
li
ci
ta
ti
o
n
. 
 
N
ee
d
 f
o
r 
in
g
re
d
ie
n
t 
la
b
el
li
n
g
 r
eg
ar
d
le
ss
 o
f 
co
n
ce
n
tr
at
io
n
. 
N
o
 u
se
 l
im
it
. 
T
h
e 
lo
w
er
 l
im
it
 f
o
r 
E
U
H
2
0
8
 i
s 
1
/1
0
 o
f 
th
e 
cl
as
si
fi
ca
ti
o
n
 
li
m
it
. 
T
h
is
 i
s 
fa
r 
to
o
 h
ig
h
 s
in
c
e 
se
n
si
ti
se
d
 i
n
d
iv
id
u
al
s 
m
a
y
 r
ea
ct
 t
o
 v
er
y
 l
o
w
 c
o
n
ce
n
tr
at
io
n
s.
 
R
E
A
C
H
/ 
re
st
ri
ct
io
n
s 
an
d
 S
D
S
 
(4
9
, 
6
5
) 
R
es
tr
ic
ti
o
n
 o
f 
u
se
 f
o
r 
so
m
e 
sk
in
 s
e
n
si
ti
se
rs
. 
S
D
S
s 
fo
r 
ch
e
m
ic
al
 
p
ro
d
u
ct
s 
(m
ix
tu
re
s)
. 
N
ic
k
el
 i
n
 a
rt
ic
le
s 
in
te
n
d
ed
 f
o
r 
p
ro
lo
n
g
ed
 s
k
in
 c
o
n
ta
ct
 (
re
le
as
e 
0
.5
 µ
g
/c
m
2
/w
ee
k
) 
a  
C
h
ro
m
iu
m
 (
V
I)
 i
n
 c
e
m
en
t 
(2
 p
p
m
) 
a
 
C
h
ro
m
iu
m
 (
V
I)
 i
n
 l
ea
th
er
 (
3
 p
p
m
) 
D
im
et
h
y
lf
u
m
ar
at
e 
(D
M
F
u
) 
in
 a
rt
ic
le
s 
(0
.1
 m
g
/k
g
).
 
G
en
er
ic
 c
o
n
ce
n
tr
at
io
n
 l
im
it
 f
o
r 
in
fo
rm
a
ti
o
n
 i
n
 S
D
S
 o
n
 
cl
as
si
fi
ed
 s
k
in
 s
en
si
ti
se
rs
 c
at
e
g
o
ry
 1
 a
n
d
 s
u
b
ca
te
g
o
ry
 1
B
 i
n
 
m
ix
tu
re
s 
is
 0
.1
%
 (
w
/w
);
 s
ee
 f
u
rt
h
er
 C
L
P
 a
b
o
v
e 
co
n
ce
rn
in
g
 
su
b
ca
te
g
o
ry
 1
A
, 
sp
ec
if
ic
 c
o
n
c
en
tr
at
io
n
 l
im
it
s 
an
d
 E
U
H
. 
 
T
h
e 
n
ic
k
el
 r
es
tr
ic
ti
o
n
 h
a
s 
n
o
t 
b
ee
n
 s
u
ff
ic
ie
n
tl
y
 p
ro
te
ct
iv
e.
 
A
 d
ef
in
it
io
n
 o
f 
“p
ro
lo
n
g
ed
” 
h
as
 b
ee
n
 p
u
b
li
sh
ed
 b
y
 E
C
H
A
, 
an
d
 w
il
l 
h
o
p
ef
u
ll
y
 s
u
p
p
o
rt
 p
re
v
en
ti
o
n
. 
T
o
o
 f
e
w
 s
k
in
 s
e
n
si
ti
se
rs
 a
re
 r
es
tr
ic
te
d
. 
S
D
S
 i
n
fo
rm
at
io
n
 o
n
 s
k
in
 s
e
n
si
ti
se
rs
 i
s 
o
ft
en
 i
n
su
ff
ic
ie
n
t 
fo
r 
p
ro
te
ct
io
n
 d
u
e 
to
 t
o
o
 h
ig
h
 g
en
er
ic
 a
n
d
 s
p
ec
if
ic
 
co
n
ce
n
tr
at
io
n
 l
im
it
s 
fo
r 
cl
as
si
fi
ca
ti
o
n
, 
an
d
 t
h
e 
la
c
k
 o
f 
in
fo
rm
at
io
n
 o
n
 n
o
n
-c
la
ss
if
ie
d
 s
en
si
ti
si
n
g
 s
u
b
st
a
n
ce
s 
a
n
d
 
m
ix
tu
re
s.
 
S
D
S
 a
re
 t
ar
g
et
ed
 a
t 
th
e 
e
m
p
lo
y
er
 a
n
d
 n
o
t 
in
te
n
d
ed
 f
o
r 
w
o
rk
er
s 
o
r 
co
n
su
m
er
s.
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E
x
am
p
le
s 
o
f 
E
U
 r
eg
u
la
ti
o
n
s 
w
it
h
 m
ea
su
re
s 
ai
m
in
g
 a
t 
th
e 
p
re
v
en
ti
o
n
 o
f 
sk
in
 s
en
si
ti
sa
ti
o
n
. 
R
eg
u
la
ti
o
n
 
(r
ef
er
en
ce
) 
M
ea
su
re
 
S
u
b
st
a
n
ce
, 
li
m
it
 v
al
u
e 
o
r 
ap
p
li
ca
ti
o
n
 
S
h
o
rt
co
m
in
g
s 
in
 r
el
at
io
n
 t
o
 p
re
v
en
ti
o
n
. 
A
sp
ec
ts
 
d
is
cu
ss
ed
 i
n
 r
ef
er
e
n
ce
s 
(7
2
, 
1
9
1
, 
1
9
2
, 
2
1
4
, 
2
2
0
) 
D
et
er
g
en
ts
 
(6
2
) 
In
fo
rm
a
ti
o
n
  
A
ll
 p
re
se
rv
at
iv
es
 s
h
al
l 
b
e 
id
en
ti
fi
ed
 o
n
 t
h
e 
la
b
el
 r
eg
ar
d
le
ss
  
o
f 
co
n
ce
n
tr
at
io
n
. 
F
ra
g
ra
n
ce
 a
ll
er
g
en
s 
sh
a
ll
 b
e 
id
en
ti
fi
ed
 o
n
 
 t
h
e 
la
b
el
 a
cc
o
rd
in
g
 t
o
 t
h
e 
C
o
sm
et
ic
s 
R
e
g
u
la
ti
o
n
. 
N
o
 u
se
 l
im
it
. 
C
o
sm
et
ic
s 
(6
4
) 
R
es
tr
ic
ti
o
n
, 
b
an
, 
in
g
re
d
ie
n
t 
la
b
el
li
n
g
 
S
o
m
e 
su
b
st
a
n
ce
s 
ar
e 
b
an
n
ed
 o
r 
se
v
er
el
y
 r
es
tr
ic
te
d
 d
u
e 
to
  
th
e 
ri
sk
 o
f 
se
n
si
ti
sa
ti
o
n
. 
E
x
a
m
p
le
s 
ar
e 
so
m
e 
p
re
se
rv
at
iv
es
, 
 
h
ai
r 
d
y
e 
an
d
 f
ra
g
ra
n
ce
 s
u
b
st
a
n
ce
s,
 a
n
d
 n
ic
k
el
. 
T
h
e 
n
a
m
es
 o
f 
al
l 
in
g
re
d
ie
n
ts
, 
ex
ce
p
t 
fr
ag
ra
n
ce
 s
u
b
st
a
n
ce
s,
 
sh
al
l 
b
e 
g
iv
e
n
 o
n
 t
h
e 
la
b
el
, 
re
g
ar
d
le
ss
 o
f 
co
n
ce
n
tr
at
io
n
. 
T
h
e 
u
se
 c
o
n
ce
n
tr
at
io
n
 o
f 
m
an
y
 s
e
n
si
ti
se
rs
 i
s 
o
ft
e
n
 t
o
o
 
h
ig
h
 f
o
r 
p
re
v
en
ti
o
n
 o
f 
in
d
u
ct
io
n
 a
n
d
 e
li
ci
ta
ti
o
n
. 
P
re
se
rv
at
iv
es
, 
fr
ag
ra
n
ce
 s
u
b
st
an
ce
s 
a
n
d
 h
ai
r 
d
y
es
 a
re
  
th
e 
m
o
st
 p
ro
m
in
e
n
t 
se
n
si
ti
se
rs
. 
O
n
ly
 2
6
 o
f 
1
0
0
 k
n
o
w
n
 f
ra
g
ra
n
ce
 s
en
si
ti
se
rs
 a
re
 c
u
rr
e
n
tl
y
 
re
q
u
ir
ed
 t
o
 b
e 
st
at
ed
 o
n
 t
h
e 
la
b
el
. 
T
h
e 
ti
m
e 
fr
o
m
 r
is
k
 a
ss
es
sm
en
t 
to
 d
ec
is
io
n
 o
n
 r
is
k
 
m
an
a
g
e
m
e
n
t 
is
 o
ft
en
 l
o
n
g
. 
 
A
n
im
al
 e
x
p
er
im
e
n
ts
 f
o
r 
th
e 
C
o
sm
et
ic
s 
R
e
g
u
la
ti
o
n
 h
av
e 
b
ee
n
 p
ro
h
ib
it
ed
 s
in
ce
 2
0
1
3
, 
li
m
it
in
g
 t
h
e 
p
o
ss
ib
il
it
y
 t
o
 
id
en
ti
fy
 n
e
w
 s
k
in
 s
e
n
si
ti
se
rs
. 
(I
n
g
re
d
ie
n
ts
 t
es
te
d
 i
n
 
an
im
al
s 
fo
r 
o
th
er
 p
u
rp
o
se
s 
m
a
y
 h
o
w
e
v
er
 s
ti
ll
 b
e 
u
se
d
  
in
 c
o
sm
et
ic
s)
. 
a 
P
re
ce
d
ed
 b
y
 o
th
er
 E
U
 o
r 
n
at
io
n
al
 l
eg
is
la
ti
o
n
. 
 
C
L
P
: 
cl
as
si
fi
ca
ti
o
n
, 
la
b
el
li
n
g
 a
n
d
 p
ac
k
ag
in
g
 o
f 
su
b
st
a
n
ce
s 
a
n
d
 m
ix
tu
re
s,
 E
C
H
A
: 
E
u
ro
p
ea
n
 C
h
e
m
ic
al
s 
A
g
e
n
c
y
, 
E
U
: 
E
u
ro
p
ea
n
 U
n
io
n
, 
E
U
H
: 
E
U
 h
az
ar
d
 
st
at
e
m
en
t,
 R
E
A
C
H
: 
R
e
g
is
tr
at
io
n
, 
E
v
al
u
a
ti
o
n
, 
A
u
th
o
ri
sa
ti
o
n
 a
n
d
 R
es
tr
ic
ti
o
n
 o
f 
C
h
e
m
ic
al
s,
 S
D
S
: 
sa
fe
ty
 d
at
a 
sh
ee
ts
. 
 
41
 42 
9.3.1 Examples of successful restrictions in the EU 
Restrictions on some skin sensitisers by REACH and the Cosmetics Regulation 
have been successful. The most prominent examples are chromium (VI) in 
cement, nickel in products that come in prolonged contact with the skin, some 
preservatives and the biocide DMFu. 
Chromium (VI) in cement is a well-known cause of allergic contact dermatitis 
in construction workers. Chromium (VI) in cement was restricted in Sweden, 
Finland and Denmark in the early 1980s, and the reduction was achieved by 
adding iron sulphate to the cement. The restriction was introduced in the EU in 
2005 (61) and contact allergy to chromium has since decreased in construction 
workers (29). However, over the past decade, chromium allergy has increased 
markedly in women, which has been attributed to chromium (VI) in leather 
products (29). Restrictions on chromium (VI) in leather products entered into 
force in 2015 (29, 58).  
Nickel is the most common cause of contact allergy. A restriction on nickel 
release from items in prolonged contact with the skin was introduced in Denmark 
in 1990, adopted by the EU in 1994, and entered into force in 2000 (Figure 10) 
(60, 133, 211). The prevalence of nickel allergy has begun to decrease in countries 
where there is compliance with the restriction, e.g. Denmark, Germany and 
Sweden (22, 66, 78, 211, 214). A decrease in nickel allergy is being observed in 
young female dermatitis patients (Figure 10). The term “prolonged contact” was 
given a strict definition by ECHA in 2014, for more efficient prevention (47). 
 
Figure 10. Frequency of contact allergy to nickel in patch tested dermatitis patients in 
Germany 1994–2010. Based on data from Garg et al. 2013 (78). Important dates in the 
EU restriction of nickel by legislation for prevention of nickel allergy are indicated on  
the x-axis: a) Nickel Directive adopted; b) Nickel Directive entered into force; c) nickel 
restriction part of REACH; d) definition of “prolonged contact” discussed by Member 
States Competent Authorities for REACH and CLP (CARACAL). A definition agreed 
upon in 2014.  
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The preservative CMIT/MIT was introduced in chemical products (mixtures) 
and cosmetics in the 1980s. A rapid increase in contact allergy was noted. 
CMIT/MIT received a low concentration limit for use in cosmetic products in 
1990 (59). Not until 2001 was CMIT/MIT classified as skin sensitiser with a  
low specific concentration limit for classification according to the Dangerous 
Substances Directive preceding the CLP Regulation (56, 129). Together, these 
actions resulted in a marked decrease in sensitisation rate among dermatitis 
patients in Europe (203). The occurrence of allergy to CMIT/MIT has, however, 
increased following the introduction of MIT at much higher concentrations in 
chemical products and cosmetics. Further restrictions of CMIT/MIT and MIT  
in cosmetic products have recently been decided (59) (Figure 11, Table 8). 
The use of MDBGN in cosmetics and chemical products increased during the 
1990s, which resulted in an alarming increase in contact allergy (Figure 11). In the 
EU, its use was banned in leave-on cosmetic products in 2005, and in all cosmetic 
products in 2008 (59) (Table 8). The use in chemical products has also decreased 
markedly. The occurrence of allergy to MDBGN among dermatitis patients has 
decreased significantly in the EU following the ban (192, 203).  
An alarming outbreak of contact allergy to the fungicide DMFu caused by 
footgear, clothing and furniture was first noted in some EU countries around 
2007. DMFu was used as fungicide in articles imported from Asia. A restriction 
was rapidly introduced in the EU (57) and the problem has declined (18, 152). 
9.4 Measures to reduce exposure to skin irritants 
The only approach including notations for irritants and corrosives is published  
by the US NIOSH (156) (Table 6).  
The definition of wet work by the German Federal Institute for Occupational 
Safety and Health (BAuA), and the measures employers need to take (technical, 
hygiene, organisational, etc.) to reduce wet work for prevention of hand eczema  
is another approach to reduce exposure to skin irritants (Section 6.1) (19).  
9.5 Guidelines for toxicology testing 
The OECD as well as industry (ECETOC) have developed several guidelines  
for testing skin absorption, irritation, corrosion and sensitisation. The relevant 
guidelines are summarised in Appendix 1. 
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Figure 11. Frequency of contact allergy to some preservatives in patch tested dermatitis 
patients at 15–16 European patch test centres (EU) and in Denmark (DK). Based on data 
from Wilkinson et al. 2002 (229), Svedman et al. 2012 (203) and Schwensen et al. 2015 
(192). Important dates concerning use, restriction and classification by legislation for 
prevention of contact allergy are indicated on the x-axis: a–j explained in Table 8. 
Table 8. Important dates concerning use, restriction and classification of some skin 
sensitising preservatives, and legislation to prevent contact allergy (Figure 11). 
Note 
Fig. 11 
Substance Use, restriction or classification Year EU 
legislation 
Ref. 
a CMIT/MIT  Max allowed conc. 0.0015% in 
cosmetic products. 
1990 CD (59) 
b MIT Introduced in chemical products. 2000 – (129) 
c CMIT/MIT  Skin sens. R43, specific conc. limit 
0.0015%. 
2001 DSD (56) 
d MDBGN Banned in leave-on cosmetic products. 2005 CD (59) 
e MIT Allowed up to 0.01% in cosmetic 
products. 
2005 CD (59) 
f MDBGN Banned in all cosmetic products. 2008 CD (59) 
g CMIT/MIT Banned in leave-on cosmetic products. 2014 CR (59) 
h MIT Banned in leave-on cosmetic products. 2016 CR (59) 
i MIT RAC opinion: H317 Skin Sens. 1A, 
specific conc. limit 0.0015%. 
2016 CLP (48) 
j MIT Allowed up to 0.0015% in rinse-off 
cosmetic products.  
2017 CR (59) 
CD: Cosmetics Directive, CLP: classification, labelling and packaging of substances and mixtures, 
CMIT/MIT: methylchloroisothiazolinone/methylisothiazolinone (3:1), CR: Cosmetics Regulation, 
DSD: Dangerous Substances Directive, EU: European Union, MDBGN: methyldibromo glutaro-
nitrile, RAC: Risk Assessment Committee, H317: May cause an allergic skin reaction, R43: May 
cause sensitisation by skin contact, Skin Sens. 1A: Category strong or extreme skin sensitiser. 
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10. Possibilities for regulation  
Airborne exposure of the skin to chemicals may to some extent result in skin 
effects as well as systemic effects. However, skin exposure and resulting effects 
are mainly a result of direct skin contact with solids, liquids and contaminated 
surfaces. Therefore, the level of chemical in air does not reflect the skin exposure. 
Hence, traditional OELs (i.e. limit concentrations in air), are insufficient for 
protection against adverse health effects by skin exposure, be it skin sensitisation, 
skin irritation, corrosion or systemic effects. Moreover, few skin sensitisers have 
an OEL. 
On the other hand, there are several possibilities for regulation in order to reduce 
dermal exposure to hazardous chemicals at the workplace. These possibilities 
(discussed in the following) include: biological limit values, warnings (notations) 
for skin absorption and sensitisation, and restrictions on occupational use. 
10.1 Biological limit values 
Biological exposure monitoring (e.g. measurement of the chemical or its meta-
bolite in urine or blood) captures all routes of exposure including skin. Therefore, 
dermal absorption of chemicals resulting in systemic effects may to some extent 
be regulated by biological limits. The EU SCOEL has decided to recommend 
biological limit values (in addition to OELs) for compounds with a skin notation 
(193). However, biological limits and biomonitoring of exposure are not suitable 
to control for local effects in the skin.  
10.2 Skin notations 
10.2.1 Dermal absorption 
The criteria for skin notation for dermal absorption vary between countries and 
organisations, resulting in divergent classifications. The criteria need to be 
harmonised and should be quantitative (as e.g. the ECETOC criteria, Table 6) 
rather than qualitative in nature. 
A drawback with the yes/no (notation/no notation) nature of skin notation  
is that it does not reflect the huge difference in dermal absorption between 
substances. A future development would be to introduce dermal indices (the  
ratio between the skin uptake and the inhalation uptake at the OEL at defined 
conditions or the skin area that results in the same systemic dose as inhalation  
at the OEL at defined conditions). 
According to the ECHA Guidance on REACH, DNELs should be established 
for likely exposure routes, including dermal DNELs for systemic effects. The unit 
should be expressed as mg/kg/day (46). Dermal DNELs for systemic effects are 
not intended for regulatory purposes per se, only for comparison against plausible 
exposure scenarios. Furthermore, as the unit implies, prior to any regulatory use 
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one would still need to incorporate data or assumptions on exposed skin area, 
exposure duration and dermal absorption rate. 
10.2.2 Skin sensitisers 
The criteria for notation of sensitising substances are, as with the skin notation  
for dermal absorption, variable and, in many instances, inadequate. The criteria 
for sensitisation notation need to be harmonised. In particular, skin and respiratory 
sensitisers should have separate notations (as introduced by the ACGIH, DFG  
and SCOEL, see Table 6), as in the CLP Regulation and its predecessor, the 
Dangerous Substances Directive. 
10.3 Classification, labelling and restrictions 
Substances fulfilling the CLP criteria for classification as skin sensitiser (H317, 
may cause an allergic reaction) shall be classified based on human, animal and/or 
other data and be subcategorised (1A and 1B) according to potency, to strengthen 
protection (Tables 4 and 7). However, only a minor part of the most important skin 
sensitisers have a harmonised (legally binding) classification. For classification  
of mixtures, the generic concentration limit is 1% for category 1 and subcategory 
1B, which generally is too high for prevention of skin sensitisation. The generic 
concentration limit for subcategory 1A is 0.1%, and lower specific concentration 
limits may be set for the most potent sensitisers, which is beneficial for protection. 
The use concentration of many skin sensitisers is, however, often so low that no 
information on their presence is given in safety data sheets or on labels, even if 
they are known to elicit allergic contact dermatitis. Mandatory ingredient informa-
tion regardless of concentration (as for cosmetics and preservatives in detergents) 
would support secondary prevention.  
Restrictions by REACH of some skin sensitisers have proven efficient for 
prevention of skin sensitisation to chromium in cement, and partly efficient to 
prevent allergy from nickel. Restrictions of additional frequent skin sensitisers  
by REACH would promote prevention. 
Many skin sensitisers (mainly preservatives and hair dye substances) are 
restricted and some are banned in cosmetic products by the Cosmetics Regulation 
for protection of consumers and occupationally exposed. This approach has been 
efficient particularly concerning contact allergy to some preservatives. The full 
ingredient labelling of cosmetic products supports secondary prevention by 
enabling exposure reduction in those who know they are sensitised.  
10.4 Restrictions on occupational use and skin exposure 
Several EU regulations on chemicals, e.g. REACH and the Cosmetics Regulation, 
address hazards and risks from skin exposure to substances by imposing 
restrictions on use or providing information about content or hazards (Table 7). 
Such restrictions can be applied also for the work environment. 
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Methods are available for quantitative or semi-quantitative assessment of skin 
exposure to metals and some hair dyes, acrylates, epoxy resin and pesticides.  
The amount of published data on skin doses of metals, hair dyes and some other 
chemicals in workplaces is increasing. The link between skin dose and elicitation 
dose in contact allergy is being established for the important skin-sensitising 
metals, some preservatives and fragrance substances. Such data on minimum 
elicitation dose (ED10) together with skin exposure doses in various occupational 
settings will support development of limits for workplace exposure.  
Restrictions on occupational use of products containing sensitising chemicals 
could be based on skin exposure limits retrieved from ED10 values (µg/cm2) for 
important skin sensitisers, and on restrictions of skin sensitising substances in 
REACH and the Cosmetics Regulation.  
Control of compliance in the workplace could be based on various measures, in-
cluding skin exposure assessments (quantitative, semi-quantitative and qualitative 
test methods), assessment of metal release from surfaces and of content in products 
in contact with the skin (including personal protective equipment, soaps and 
creams). 
11. Research needs 
Several aspects of skin exposure, exposure assessment and health effects require 
additional research.  
Methods for assessment of skin exposure to hazardous chemicals other than 
those mentioned in Section 10.4 need to be developed, standardised and validated. 
The relative importance of dose, duration and frequency of exposure to skin 
sensitisers, irritants and other hazardous chemicals is largely unknown. These 
factors need to be clarified since such knowledge is vital for health risk assess-
ment, prevention and prioritisation of measures. Dose-response studies of 
elicitation of contact allergy can be used for risk assessment, risk management, 
and setting no-effect limits for skin sensitisers. Dose-response studies to 
determine elicitation thresholds (ED10) of important skin sensitisers in already 
sensitised individuals are needed. Such knowledge will contribute significantly to 
setting relevant and protective limits for occupational skin exposure. 
Use of and exposure to nanomaterials is constantly expanding. It is well known 
that small metal particles release more metal than larger ones. How this affects 
skin doses and health effects, including sensitisation, is unknown. Knowledge 
about how risks are related to particle size and other properties is thus needed. 
Current alternative methods for determination of skin sensitisation potential  
(in silico and in vitro methods) are only indicative. They cannot yet predict 
sensitising potency, and prediction of non-sensitisers, pre- and pro-haptens and 
cross-reactivity is poor. This is a complex area that still relies mainly on animal 
tests. It is urgent to develop and validate methods to test for skin sensitisation that 
can fill these gaps.  
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12. Summary 
Julander A, Boman A, Johanson G, Lidén C. The Nordic Expert Group for 
Criteria Documentation of Health Risks from Chemicals. 151. Occupational skin 
exposure to chemicals. With focus on skin exposure assessment, skin sensitisation 
and prevention by exposure reduction. Arbete och Hälsa 2018;52(3):1–69. 
 
Skin exposure can be due to airborne deposition, contact with solid materials, 
liquids, contaminated surfaces or intentional application. Skin exposure, especially 
if repeated or prolonged, may result in dermal penetration and absorption, skin 
sensitisation and irritant reactions. Occupational skin diseases represent up to 30% 
of the occupational diseases in Europe. The most important exogenous risk factors 
are exposure to skin sensitising substances (contact allergens), skin irritants and 
wet work. Skin exposure to chemicals can also cause systemic effects and skin 
cancer.  
Skin exposure to contact allergens may cause induction of contact allergy, and 
re-exposure of a sensitised individual to the substance may result in elicitation of 
allergic contact dermatitis, the clinical disease. Contact allergy is distinct from 
IgE-mediated allergy in asthma and rhinitis. The most common skin sensitisers 
are metals, preservatives, plastic and rubber chemicals, fragrance substances and 
hair dyes.  
Occupational exposure limit values for airborne exposure are irrelevant and 
insufficient for protection against adverse health effects from skin exposure. 
Meanwhile, there are several possibilities for regulation in order to reduce dermal 
exposure to hazardous chemicals at the workplace, including: biological limit 
values, skin notations as warnings for skin absorption and sensitisation, and 
restrictions on occupational use.  
Methods are now available for quantitative or semi-quantitative assessment  
of skin exposure to metals and some hair dyes, acrylates, epoxy resins and 
pesticides. The link between skin dose and elicitation dose in contact allergy is 
being established for skin sensitising metals, some preservatives and fragrances. 
Such data can support the development of limits for skin exposure in the 
workplace. Control of compliance in the workplace could be based on various 
measures, including assessment of skin exposure, of metal release from surfaces, 
and concentration in products in contact with the skin. 
 
 
 
 
 
 
 
Keywords: contact allergy, dermal absorption, dermatitis, skin irritant, skin 
exposure, skin notation, skin sensitiser.  
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13. Summary in Swedish 
Julander A, Boman A, Johanson G, Lidén C. The Nordic Expert Group for 
Criteria Documentation of Health Risks from Chemicals. 151. Occupational skin 
exposure to chemicals. With focus on skin exposure assessment, skin sensitisation 
and prevention by exposure reduction. Arbete och Hälsa 2018;52(3):1–69. 
 
Hudexponering för kemikalier kan ske genom kontakt med luft, fasta material, 
vätskor, kontaminerade ytor eller genom avsiktlig applicering. Hudexponering 
kan orsaka upptag genom huden, hudsensibilisering och hudirritation, i synnerhet 
vid upprepad eller långvarig exponering. Upp till 30% av yrkessjukdomarna i 
Europa utgörs av hudsjukdomar. De viktigaste yttre riskfaktorerna är exponering 
för hudsensibiliserande ämnen (kontaktallergen), hudirriterande ämnen och 
våtarbete. Hudexponering för kemikalier kan också orsaka systemeffekter och 
hudcancer. 
Hudexponering för hudsensibiliserande ämnen kan inducera kontaktallergi  
och upprepad exponering kan hos en redan sensibiliserad person orsaka allergiskt 
kontakteksem, den kliniska sjukdomen. Kontaktallergi är en annan form av  
allergi än den vid IgE-medierad astma och rinit. De ämnen som oftast orsakar 
kontaktallergi är metaller, konserveringsmedel, plast- och gummikemikalier, 
parfymämnen och hårfärgämnen. 
Gränsvärden för luftburen exponering i arbetsmiljön är inte relevanta eller 
tillräckliga för att skydda mot negativa hälsoeffekter av hudexponering. Det finns 
flera möjligheter att genom lagstiftning begränsa hudexponeringen för farliga 
ämnen i arbetsmiljön, till exempel biologiska gränsvärden, varning/notering för 
hudupptag och sensibilisering, och begränsningar av yrkesmässig användning av 
kemikalier. 
Det finns nu kvantitativa och semikvantitativa metoder för att mäta hud-
exponeringen för metaller och vissa hårfärgämnen, akrylater, epoxiharts och 
bekämpningsmedel. Sambandet mellan huddos och den dos som orsakar eksem 
vid kontaktallergi har fastställts för ett antal metaller, konserveringsmedel och 
parfymämnen. Sådan kunskap kan stödja arbetet med att ta fram gränsvärden  
för hudexponering i arbetsmiljön. Kontroll och tillsyn på arbetsplatser skulle 
kunna baseras på olika mått, bland annat genom att mäta hudexponering, 
frisättning av metaller från ytor och koncentrationen i produkter som kommer  
i kontakt med huden.  
 
 
 
 
 
 
Nyckelord: eksem, hudexponering, hudirritation, hudmärkning, hudsensibilisering, 
hudupptag, kontaktallergen, kontaktallergi.  
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Appendix 1. Guidelines for skin toxicology by OECD and 
ECETOC 
Table A. OECD guidelines for testing of chemicals (162). 
No. Title Endpoint Year 
402 Acute dermal toxicity Systemic toxicity after single skin exposure  
to test chemical. 
2017 
404 Acute dermal 
irritation/corrosion 
The degree of irritancy as seen on rabbit skin 
after exposure to test chemical. 
2015 
406 Skin sensitisation Rate, extent and degree of skin reaction in 
guinea pigs after induction and challenge 
exposure to test chemical. 
1992 
410 Repeated dose dermal 
toxicity: 21/28-day study 
Systemic toxicity after repeated skin exposure 
to test chemical. 
1981 
411 Subchronic dermal toxicity: 
90-day study 
Systemic toxicity after repeated skin exposure 
to test chemical. 
1981 
427 Skin absorption: in vitro 
method 
Rate or amount of test chemical absorbed into 
the skin. 
2004 
428 Skin absorption: in vitro 
method 
Amount of test chemical absorbed into and 
through the skin. 
2004 
429 Skin sensitisation: local 
lymph node assay 
Relationship of incorporation of 3H-thymidin 
in cells in draining auricular lymph nodes 
between mice exposed to test chemical and 
mice exposed to vehicle only. 
2010 
430 In vitro skin corrosion: 
transcutaneous electrical 
resistance test method (TER) 
Reduction of resistance in rat skin after 
exposure to test chemical. 
2015 
431 In vitro skin corrosion: 
reconstructed human 
epidermis (RHE) test method 
Time to viability loss of cells in reconstructed 
human epidermis by enzymatic conversion of 
MTT after exposure to test chemical. 
2016 
432 In vitro 3T3 NRU 
phototoxicity test 
Skin phototoxicity. 2004 
435 In vitro membrane barrier test 
method for skin corrosion 
Time to colour change in a detection fluid 
after absorption of test chemical through a 
collagen matrix. 
2015 
439 In vitro skin irritation: 
reconstructed human 
epidermis test method 
Time to viability loss of cells in reconstructed 
human epidermis by enzymatic conversion of 
MTT after exposure to test chemical. 
2015 
442A Skin sensitization: local 
lymph node assay: DA 
Relationship of ATP in draining auricular 
lymph nodes between mice exposed to test 
chemical and mice exposed to vehicle only. 
2010 
442B Skin sensitization: local 
lymph node assay: BrdU-
ELISA 
Relationship of incorporation of BrdU in cells 
in draining auricular lymph nodes between 
mice exposed to test chemical and mice 
exposed to vehicle only. 
2010 
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Table A. OECD guidelines for testing of chemicals (162). 
No. Title Endpoint Year 
442C In chemico skin sensitisation 
direct peptide reactivity assay 
(DPRA) 
Addressing the molecular initiating event 
leading to skin sensitisation. Supporting  
the discrimination between skin sensitisers 
and non-sensitisers. 
2015 
442D In vitro skin sensitisation 
ARE-Nrf2 luciferase test 
method (also known as 
KeratinoSens™) 
Addressing the second key event of the  
skin sensitisation AOP. Supporting the 
discrimination between skin sensitisers  
and non-sensitisers. 
2015 
442E In vitro skin sensitisation: 
human cell line activation test 
(h-CLAT) 
Addressing the third key event of the  
skin sensitisation AOP. Supporting the 
discrimination between skin sensitisers  
and non-sensitisers. 
2016 
AOP: adverse outcome pathway, ATP: adenosine triphosphate, BrdU: 5-bromo-2-deoxyuridine, 
ELISA: enzyme-linked immunosorbent assay, MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide, NRU: neutral red uptake, OECD: Organisation for Economic Co-operation 
and Development. 
 
 
 
Table B. ECETOC monographs (45). 
No. Title Year 
14 Skin sensitisation testing 1990 
15 Skin irritation 1990 
20 Percutaneous absorption 1993 
29 Skin sensitisation testing for the purpose of hazard identification and risk 
assessment 
2000 
32 Use of human data in hazard classification for irritation and sensitisation 2002 
ECETOC: European Centre for Ecotoxicology and Toxicology of Chemicals. 
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Appendix 2. Previous NEG criteria documents 
NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Acetonitrile 1989:22, 1989:37* 
Acid aerosols, inorganic 1992:33, 1993:1* 
Acrylonitrile 1985:4 
Allyl alcohol 1986:8 
Aluminium and aluminium compounds 1992:45, 1993:1*, 2011;45(7)*D 
Ammonia 1986:31, 2005:13* 
Antimony 1998:11* 
Arsenic, inorganic 1981:22, 1991:9, 1991:50* 
Arsine 1986:41 
Asbestos 1982:29 
Benomyl 1984:28 
Benzene 1981:11 
1,2,3-Benzotriazole 2000:24*D 
Boric acid, Borax 1980:13 
1,3-Butadiene 1994:36*, 1994:42 
1-Butanol 1980:20 
γ-Butyrolactone 2004:7*D 
Cadmium 1981:29, 1992:26, 1993:1* 
7/8 Carbon chain aliphatic monoketones 1990:2*D 
Carbon monoxide 1980:8, 2012;46(7)* 
Carbon nanotubes 2013;47(5)* 
Ceramic Fibres, Refractory 1996:30*, 1998:20 
Chlorine, Chlorine dioxide 1980:6 
Chloromequat chloride 1984:36 
4-Chloro-2-methylphenoxy acetic acid 1981:14 
Chlorophenols 1984:46 
Chlorotrimethylsilane 2002:2 
Chromium 1979:33 
Cobalt 1982:16, 1994:39*, 1994:42 
Copper 1980:21 
Creosote 1988:13, 1988:33* 
Cyanoacrylates 1995:25*, 1995:27 
Cyclic acid anhydrides 2004:15*D 
Cyclohexanone, Cyclopentanone 1985:42 
n-Decane 1987:25, 1987:40* 
Deodorized kerosene 1985:24 
Diacetone alcohol 1989:4, 1989:37* 
Dichlorobenzenes 1998:4*, 1998:20 
Diesel engine exhaust 2016;49(6)*D 
Diesel exhaust 1993:34, 1993:35* 
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NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Diethylamine 1994:23*, 1994:42 
2-Diethylaminoethanol 1994:25*N 
Diethylenetriamine 1994:23*, 1994:42 
Diisocyanates 1979:34, 1985:19 
Dimethylamine 1994:23*, 1994:42 
Dimethyldithiocarbamates 1990:26, 1991:2* 
Dimethylethylamine 1991:26, 1991:50* 
Dimethylformamide 1983:28 
Dimethylsulfoxide 1991:37, 1991:50* 
Dioxane 1982:6 
Endotoxins 2011;45(4)*D 
Enzymes, industrial 1994:28*, 1994:42 
Epichlorohydrin 1981:10 
Ethyl acetate 1990:35* 
Ethylbenzene 1986:19 
Ethylenediamine 1994:23*, 1994:42 
Ethylenebisdithiocarbamates and Ethylenethiourea 1993:24, 1993:35* 
Ethylene glycol 1980:14 
Ethylene glycol monoalkyl ethers 1985:34 
Ethylene oxide 1982:7 
Ethyl ether 1992:30* N 
2-Ethylhexanoic acid 1994:31*, 1994:42 
Flour dust 1996:27*, 1998:20 
Formaldehyde 1978:21, 1982:27, 2003:11*D 
Fungal spores 2006:21* 
Furfuryl alcohol 1984:24 
Gasoline 1984:7 
Glutaraldehyde 1997:20*D, 1998:20 
Glyoxal 1995:2*, 1995:27 
Halothane 1984:17 
n-Hexane 1980:19, 1986:20 
Hydrazine, Hydrazine salts 1985:6 
Hydrogen fluoride 1983:7 
Hydrogen sulphide 1982:31, 2001:14*D 
Hydroquinone 1989:15, 1989:37* 
Industrial enzymes 1994:28* 
Isoflurane, sevoflurane and desflurane 2009;43(9)* 
Isophorone 1991:14, 1991:50* 
Isopropanol 1980:18 
Lead, inorganic 1979:24, 1992:43, 1993:1* 
Limonene 1993:14, 1993:35* 
Lithium and lithium compounds 2002:16* 
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NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Manganese 1982:10 
Mercury, inorganic 1985:20 
Methacrylates 1983:21 
Methanol 1984:41 
Methyl bromide 1987:18, 1987:40* 
Methyl chloride 1992:27*D 
Methyl chloroform 1981:12 
Methylcyclopentadienyl manganese tricarbonyl 1982:10 
Methylene chloride 1979:15, 1987:29, 1987:40* 
Methyl ethyl ketone 1983:25 
Methyl formate 1989:29, 1989:37* 
Methyl isobutyl ketone 1988:20, 1988:33* 
Methyl methacrylate 1991:36*D 
N-Methyl-2-pyrrolidone  1994:40*, 1994:42 
Methyl-tert-butyl ether 1994:22*D 
Microbial volatile organic compounds (MVOCs) 2006:13* 
Microorganisms 1991:44, 1991:50* 
Mineral fibers 1981:26 
Nickel 1981:28, 1995:26*, 1995:27 
Nitrilotriacetic acid 1989:16, 1989:37* 
Nitroalkanes 1988:29, 1988:33* 
Nitrogen oxides 1983:28 
N-Nitroso compounds 1990:33, 1991:2* 
Nitrous oxide 1982:20 
Occupational exposure to chemicals and hearing impairment 2010;44(4)* 
Oil mist 1985:13 
Organic acid anhydrides 1990:48, 1991:2* 
Ozone 1986:28 
Paper dust 1989:30, 1989:37* 
Penicillins 2004:6* 
Permethrin 1982:22 
Petrol 1984:7 
Phenol 1984:33 
Phosphate triesters with flame retardant properties 2010;44(6)* 
Phthalate esters 1982:12 
Platinum 1997:14*D, 1998:20 
Polychlorinated biphenyls (PCBs) 2012;46(1)* 
Polyethylene,  1998:12* 
Polypropylene, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polystyrene, Thermal degradation products in the processing 
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